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ABSTRACT 
 
 Direct-write assembly is used to fabricate 3D microperiodic scaffolds composed of 
hyaluronic acid (HA), a natural, biocompatible, biodegradeable polymer, for cell culture and 
tissue engineering applications.  HA is functionalized with UV-curable glycidyl methacrylate 
(GM) and printed to create 3D scaffolds with filament diameters ranging from 10-250 µm.  The 
potential for 3D HAGM scaffolds in injectable applications is demonstrated by flowing  
1.5 mm x1.5 mm scaffolds through a channel tapered to 0.5 mm x 0.5 mm x 0.5 mm without 
damage.  The compressive moduli of HAGM scaffolds can be tuned by varying the spacing 
between pattern filaments, and optimal designs exhibit values akin to the compressive modulus 
of articular cartilage.   
 Porcine adipose derived stem cells (ASCs) are cultured on HAGM scaffolds with the aim 
of inducing chondrogenic differentiation.  Cartilage formation on 3D printed scaffolds is better 
distributed within the scaffolds relative to 2D controls, and new tissue is best able to infiltrate 
their microperiodic structure when a cell-adhesive RGD peptide is incorporated.  To achieve the 
most effective distribution of ASCs within the 3D scaffolds, seeding of cells within dilute 
mixtures of HAGM is explored.  Such mixtures may be combined with 3D printed scaffolds to 
produce a cell-laden scaffold that provides both a substrate for cartilage formation and pervasive 
structural elements that bear compressive loads when used in in vivo tissue repair applications.  
ASCs within the 2% HAGM bulk gels proliferate, transport, and undergo chondrogenic 
differentiation.  Finally, HAGM scaffolds are implanted in porcine mandibular bone to confirm 
their biocompatibility and potential to support tissue growth in in vivo models. 
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CHAPTER 1 
  
INTRODUCTION 
1.1 Introduction 
Recent emphasis on biomimetic designs has advanced the field of tissue engineering 
beyond two dimensions into the domain of three-dimensional (3D) platforms for both in vitro 
and in vivo replication, regeneration, and replacement of biological tissues.  Tissue damage 
repair, organ transplant needs, and alternatives for disease and drug therapy models have driven 
the demand for new and innovative technologies for replicating 3D microenvironments within 
the body.  
As tissue engineering evolves, a variety of fabrication methods have made significant 
contributions towards producing 3D, biologically relevant structures for culture and growth of 
cells and tissues.  While random, porous constructs have been popular due to their ease of 
fabrication, relatively low costs, and large sample volumes, recent methods such as 
stereolithography[1,2,3], colloidal templating[4], and 3D additive manufacturing [5,6,7,8] have 
been used to produce architectures with high a degree of control over porosity, orientation, and 
other features of the microenvironment that may affect cell and tissue behavior. 
Materials selection is critical in the design of 3D constructs for tissue engineering 
applications.  Key parameters that must be considered include biocompatibility, biodegradability, 
and cell-substrate interactions.  Many naturally derived biopolymers meet these criteria, and are 
therefore ideal candidates.  Hyaluronic acid (HA) is a large, unbranched, negatively charged 
polysaccharide found in extracellular matrix (ECM) and synovial fluids that naturally degrades 
via hyaluronidase and has proven to be well suited to tissue engineering with a variety of cell 
types and tissues.  Functional groups along the backbone of the polymer allow for chemical 
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modification to tailor HA towards specific tissue engineering applications[9,10,11,12].  
Functionalization with UV-crosslinkable methacrylate groups is especially useful for patterning 
3D gels.  In addition, co-polymerization with other biocompatible polymers such as (poly 
ethylene) glycol diacrylate (PEGDA), which further allows grafting of integrin-binding peptides 
derived from ECM like RGD to form hydrogels that promote higher levels of cell attachment, a 
significant advantage for tissue engineering platforms[13,14,15,16].  
When considering clinical applications, injectable 3D scaffolds are attractive as 
minimally invasive alternatives for regenerative therapies that would otherwise require traumatic 
surgical implantation.  HA has been used in its natural form for basic injection therapies[17], and 
functionalized HA has been used for injecting crosslinked hydrogels [18,19,20]. Each of these 
strategies, however, relies on space-filling, soft gels without defined geometry; hence, they do 
not incorporate the design advantages of previously discussed 3D fabrication methods.  
Structural support and controlled architecture are not presently available in injectable HA 
systems, though significant steps forward have been made with other material systems[21].  
While 3D printing of HA has been demonstrated [22,23], the ability to create spanning, periodic  
architectures have not yet been accomplished using those methods. 
 
1.2 Thesis Scope 
 The objectives of this thesis are to synthesize, pattern, and characterize 3D scaffolds 
composed of UV-curable hyaluronic acid and to examine their applications in cell culture and 
tissue engineering.  
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1.3 Thesis Organization  
 In chapter 2, pertinent literature on HA and its functionalization methods is presented as 
well as a brief overview of 3D tissue engineering.  In chapter 3, the design and synthesis of a 
UV-curable HA ink suitable for direct-write assembly are discussed.  In addition, the fabrication 
of 3D HA scaffolds is described.  In chapter 4, the application of these scaffolds for cell culture 
and tissue engineering is described.  Finally, the thesis conclusions are provided in chapter 5. 
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CHAPTER 2 
 
LITERATURE REVIEW 
2.1 Introduction 
The chapter begins by providing an overview of hyaluronic acid (HA) and its 
functionalization and role in biological systems.  Next, tissue engineering and regenerative 
medicine will be reviewed, with an emphasis on tissue mechanics, stem cells, and three-
dimensional (3D) tissue engineering and fabrication.  The use of HA in 3D tissue engineering 
and related injectable approaches is specifically highlighted.  Finally, a novel 3D printing 
approach, known as direct-write assembly, is introduced with an emphasis on the ink design 
requirements and its potential applications in tissue engineering. 
2.2 Hyaluronic Acid 
Tissue engineering scaffolds should ideally promote natural wound healing and tissue 
growth in implant sites.  Hence, biocompatibility, biodegradation, and functionality are key 
features of well-designed tissue engineering constructs.  Naturally derived biopolymers are ideal 
candidates for scaffold materials where tissue regeneration is a primary goal.  Hyaluronic acid 
(HA) is a large, unbranched, negatively charged polysaccharide composed of repeating units of 
glucaronic acid and N-acetylglucosamine (Figure 2.1). 
 
Figure 2.1  Chemical structure of hyaluronic acid.[24] 
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  It is naturally degraded in the presence of hyaluronidase, which is also present in the 
body. The prevalence of HA in the extracellular matrix (ECM) and its role in various cell 
functions such as motility, proliferation, and angiogenesis have made it an attractive candidate 
material for tissue engineering.  Cells are able to interact with HA through cell-surface receptors 
CD44 and RHAMM to induce this cellular activity. [25] In addition, the functional groups along 
the polymer backbone present sites for chemical modification that permit the polymer to be 
tailored towards specific applications.  As a result, HA functionalization, tissue engineering, and 
injectable motifs have been extensively investigated.   
The primary site for functionalization of HA is in the exposed alcohol functional group 
on the N-acetylglucosamine unit.   Modification of this group is often used to form 
photocrosslinkable moieties that allow chemical gelation of the polymer when exposed to UV 
light.  The two primary methods used to chemically modify HA with photocrosslinkable 
functional groups are: (1) a free radical polymerization with methacrylic anhydride in the 
presence of acid [9,26-29] and (2) a ring opening reaction with glycidyl methacrylate. [10,30]  
These reactions, shown in Figure 2.2a, allow up to 90% of the available hydroxyl groups to be 
functionalized.  The presence of methacrylate groups on the polymer backbone can be quantified 
by NMR following each reaction (Figure 2.2b).   
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Figure 2.2  Methacrylation of HA. (a) reaction mechanism for glycidyl methacrylate[10] and 
methacrylic anhydride[26] reactions. (b)
 1
H NMR of glycidyl methacrylated HA.  
Peaks at b and c are indicative of methacrylate functionalization.[10] 
 
Burdick et al. demonstrated that UV-cured HA hydrogels could have controllable degradation 
rates and mechanical properties by varying the degrees of methacrylation through the 
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methacrylic anhydride reaction.[29]  Bencherif et al. showed similar results for the glycidyl 
methacrylate reaction, demonstrating similar cell morphology and attachment across the degrees 
of methacrylation.[10] In my thesis, we build upon the synthesis of HA-glycidyl methacrylate 
(HAGM) to form a UV-curable hydrogel ink for printing of 3D HA scaffolds.  
Thiol chemistry is another strategy that has been used for crosslinking of biocompatible 
HA materials, which takes advantage of the carboxyl group on the glucaronic acid unit (Figure 
2.3a).[22,31,32]  In one form of this method, HA is modified with a di-thiol containing 
dihydrazide in the presence of 3-(3-dimethylaminopropyl)carbodiimide)(EDCI) activating agent.  
The gel forms by oxidation in air, and a simple reduction of the di-thiol bridge forms a reversible 
gel.  No alternative energy source is needed for crosslinking, and gels form within minutes.  
Crosslinked gels are non-cytotoxic, making them suitable for tissue engineering.[31]  Other 
crosslinking methods that utilize the carboxyl group on HA have been developed with aldehydes 
[33], azides [34], and tyramines [35] 
HA can also be grafted with other polymer molecules to alter functionality and tailor HA 
to design strategies.  Polyethylene glycol and poly(D,L-lactic acid-co-glycolic acid), well known 
biocompatible polymers, have been co-polymerized with hyaluronic acid to tailor degradation 
rates and the release of active compounds.[14,36,37,38]  A Michael’s addition of RGD peptide 
sequences to HA or its derivative functional forms makes HA hydrogels more prone to cell 
attachment.[13,38]  Macromolecules with unique functionality such as thermosensitive Pluronic 
F127 have been grafted on HA to combine the biofunctionality of HA with the unique 
temperature-sensitive characteristics of the Pluronic (Figure 2.3b).[39]  Despite cytotoxic issues 
with pure Pluronic, the co-polymer demonstrated viable chondrocyte cultures over 4 weeks and 
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maintained the unique rheological properties characteristic of Pluronic F127 micelle 
formation.[39] 
 
Figure 2.3  Reaction schemes for alternative HA functionalization (a) Di-thiol [31] and (b) 
Pluronic F127 co-polymerization. [39] 
 
2.3 Tissue Engineering and Regenerative Medicine 
Tissue engineering has developed over the past two decades to meet the demand for the 
replacement and regeneration of tissue and organs due to loss, catastrophic damage, and disease.  
Both in vitro and in vivo models have been utilized to mimic the complex microenvironment 
surrounding cell and tissue development.  Bioactivity, degradation, soluble factors, mechanical 
cues, and fluid flow are all elements contributing to the complexity of the in vivo environment, 
which must be considered in tissue engineering. 
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2.3.1 Tissues of the Body and Associated Mechanics  
The body is a composite composed of organic and inorganic materials, including fluids, 
tissues, and cells that display a wide range of characteristics that present challenges to tissue 
engineers.  3D scaffolds should reasonably mimic the target tissue for growth or regeneration.  
Not only do target tissues differ in structure and morphology, but their mechanical properties and 
responses throughout the human body vary greatly as well.  As a result, a basic understanding of 
these differences is important for tissue engineering.  There are four different types of tissue in 
the body: epithelial, muscle, nervous, and connective.  This thesis focuses on connective tissues 
that support and connect other tissues throughout the body, particularly bone and cartilage.  Bone 
and cartilage are extremely relevant to tissue engineering because of their critical relationship to 
mechanical support and movement.  Annually, over 250,000 surgeries are directed at the repair 
of cartilage in tendons and ligaments in the United State alone.[40]  The high demand for 
cartilage tissue provides the impetus for this thesis work.   
Prior to engineering replacement tissue, it is important to understand the structure and 
mechanics of relevant connective tissues. Uncalcified articular cartilage has cells distributed 
throughout a collagen matrix that is anchored in the calcified layer, forming a three dimensional 
network of interlacing fibers that rise to the surface and turn parallel to the articular surface.[41]  
The Young’s modulus of cartilage is 1 MPa, while pure bone mineral is extremely stiff and 
strong with a Young’s modulus of 165 GPa.  Human femur bone, a combination of these two 
tissues, is between these two values at ~18 GPa.[42]  Research efforts in tissue engineering of 
each of these tissue types must carefully consider these mechanical characteristics of native 
tissue.  The work in this thesis addresses how 3D HA scaffolds can be engineered to exhibit the  
material properties of cartilage and bone tissue. 
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2.3.2 Stem Cells and Effects of the Mechanical Microenvironment 
Within tissue engineering, there is a fundamental requirement for cell sources that are 
capable of forming specific tissue types under properly controlled conditions. Stem cells are 
traditionally defined as cells that can proliferate while maintaining an undifferentiated 
phenotype, which are capable of differentiating into specialized cell types.  There are a wide 
variety of stem cell types, but this work is focused on adult stem cells, which are primarily 
limited to specific cell lineages.  Unlike embryonic stem cells, which can differentiate into cell 
types from all three germ layers, mesenchymal stem cells (MSCs) and adipose derived stem cells 
(ADSCs) are limited in their differentiation to particular lineages.  They remain ideal candidates 
for tissue engineering because of their ability to differentiate into most tissues of the body, 
including cartilage, bone, fat, muscle and neurons.  Prior to differentiation, they can be 
maintained in an undifferentiated state over the course of multiple in vitro passages. [34,43] 
Discovery of MSCs was pioneered by Freidenstein et al. when they isolated polystyrene-
adherent cells from bone marrow with tight fibroblast-like colony formations that were able to 
differentiate into both bone and cartilage.[44]  These cells were soon found to expand to several 
other cell types, including adipocytes and myocytes [45]. The field grew rapidly and now yields 
over 10,000 publications annually.  However, the procedure to obtain MSCs is highly invasive, 
available cell counts are low, and differentiation ability typically decreases with age.  An 
alternative cell source that has potential to bypass these issues is ADSCs, taken from fat deposits 
removed during liposuction.  Adipose tissue has been shown to contain stem cells with similar 
morphology and function to bone marrow-derived MSCs.[46]  With nearly a half million 
liposuctions conducted per year in which the liposate is typically discarded, there is a large pool 
11 
 
of available cells.  In addition, ADSCs can more easily be extracted from patients for potential 
autologous therapies.[47] 
Cell differentiation of both MSCs and ADSCs has been proven to be highly dependent on 
extracellular cues.  In addition to genetic and molecular in-cell markers, substrate stiffness has a 
major influence on stem cell fate.  The extracellular matrix (ECM), which provides mechanical 
cues, has been carefully examined with respect to elasticity and geometry.  Contractile forces 
arise as cells attach to a substrate, creating tensile stress on the cytoskeleton of the cell and 
cascading to the biochemical cues that determine differentiation.[48]  Engler et al. showed that 
varying substrate stiffness, for instance, can affect stem cell fate.  When seeded, MSCs initially 
exhibit similar morphology.  After 96 hours, however, cells seeded on 0.1-1kPa substrates spread 
and showed the greatest expression of neurogenic transcripts.  Substrates of stiffness 8-17 kPa 
led to spindle shaped, muscle-like cells with protein expression closest to muscle cells. Cells 
seeded on the stiffest 24-40 kPa substrate mimicked the morphology of osteoblasts and more 
strongly expressed osteogenic factors (Figure 2.1a).[49] 
Geometric cues from the substrate can also influence stem cell fate.  Independent of 
soluble factors, varying geometric features that altered contractile forces on the cell culture are 
able to induce differentiation along adipogenic and osteogenic pathways (Figures 2.4b and 
2.4c).[50]  Patterned PDMS micro-features are popular for determining mechanical cues on stem 
cell fate.  MSCs cultured on longer posts (lower substrate stiffness) contained disorganized actin 
filaments and formed lipid droplets, indicating adipocyte differentiation (Figure 2.4d).[51] 
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Figure 2.4   Effect of mechanical cues on stem cells. (a) Optical images of MSC morphology on 
polyacrylamide gels of varying stiffness.[49] (b) Immunofluorescent image of cells in 
flower and start shapes stained for F-actin (green), vinculin (red), and nuclei (blue). 
(c) Differentiation of MSCs along two cell fates on two geometries.[50] (D) SEMs of 
hMSCs on PDMS posts of varying height.[51] (scale bars: a, b, 20 µm; d (left to 
right), 50 µm, 30 µm, 10 µm) 
 
Artificially engineered ECMs are a pathway through which researchers have proven the potential 
to promote specific tissues for regenerative medicine.  Moving beyond the mechanical cues of 
planar surfaces demonstrated above, the fabrication of well-controlled 3D constructs is an 
important next step for properly mimicking the in vivo environment of stem cells in tissue 
engineering. 
2.3.3 3D Tissue Engineering  
A major goal of tissue engineering is to proliferate and manipulate cells in an 
environment that directly mimics the natural in vivo environment.  Planar surfaces like those 
described above are useful for extracting information about specific extracellular cues, but they 
are inadequate for representing the 3D environment in which cells and tissue develop in the 
body. For example, in a seminal study in 1997, Weaver et al. used a cell line of tumorigenic and 
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non-malignant cells that were both derived from the same HMT-3522 mammalian cells, offering 
a unique tool for addressing the mechanisms behind malignant conversion in cancer cells. [52]  
The study revealed that the β1 integrin was integral to tumorigenic cell fate.  Since this molecule 
participates in cell-matrix adhesions, unique characteristics were found when the studies were 
done in 3D.  By using an antigen to the β1 integrin, tumorigenic cells were shown to revert to 
their original, non-malignant morphologies (Figure 2.5a), something never shown in 2D. Tissue 
engineering  now emphasizes the 3D models for regenerative research to best simulate the 
environment and effects in vivo.  
 
 
 
Figure 2.5  Significance of third dimension in tissue engineering. (a) HMT-3522 cells (a) that 
become tumorigenic (a’) revert to benign morphology (a”).[52] (b) 3D culture of 
mouse embryonic stem cells in osteogenic media induces mineralization, indicated by 
black Von Kossa staining (white arrows).[53] (scale bars: a, 16 µm; b, 250µm). 
 
Garreta et al. further demonstrated the necessity of the third dimension for stem cells in 
their study on osteogenic differentiation on self-assembling peptide scaffolds.[53]   Loss of 
pluripotency was confirmed with fluorescently labeled Oct4 promoters in both 2D and 3D 
cultures of mouse embryonic stem cells, but mineralization associated with osteogenic 
differentiation was significantly higher in the 3D scaffolds compared to traditional 2D culture 
methods (Figure 2.5b).  Morphology of cells derived from rat models were also matched only by 
the in vitro cultures utilizing 3D substrates.   
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2.3.4 3D Matrix and Scaffold Fabrication 
 3D tissue engineering initially relied on traditional materials, like Matrigel, to provide a 
research foundation.[52]  However, there is a plethora of exciting materials and fabrication 
methods that have recently emerged for producing 3D constructs.  Materials, such as collagen 
and gelatin, are widely utilized in the formation of random 3D porous structures due to their 
presence in the ECM.  3D fabrication techniques such as colloidal templating, stereolithography, 
and micro-extrusion broaden the scope of available materials to include chitosan, UV curable 
polymers, and polysaccharides. 
 Random 3D porous matrices are popular due to their ease of fabrication, low 
manufacturing costs, and large sample volumes produced by solution forming[54,55], particle 
leaching[56,57], gas foaming[58,59], or electrospinning[60,61] (Figure 2.6).  
 
Figure 2.6  Random 3D architectures for tissue engineering. (a) solution forming of collagen[55] 
(b) sucrose particle leaching in gelatin matrix[56] (c) poly (D,L –lactic acid) scaffold 
foamed with CO2 gas [58] (d) electrospun collagen nanofibers.[60] (scale bars: a, b, c, 
300µm; d, 5 µm) 
 
Solution forming, the most common method, relies on cooling dilute polymer suspensions to 
extremely low temperatures to induce ice crystal formation.  Upon exposing this material to 
millitorr pressures, the ice crystals are sublimated, leaving behind a porous polymer network for 
tissue engineering.  Collagen, one of the major proteins found in the ECM, is a popular matrix 
material.  To date, researchers have also incorporated glycosaminoglycans, another primary 
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component of the ECM.  The final result is a 3D matrix that is closely mimics the in vivo 
environments of cells.[62]  The primary drawback is a lack of control over spatial architecture.  
 To address this limitation, researchers have used methods such as colloidal templating 
[63,64], stereolithography [2,3,65,66], and 3D filamentary printing [7,67,68] (Figure 2.7). 
 
 
 
Figure 2.7  3D architectures for tissue engineering. (a) Colloidal templating - chitosan inverse 
opal for mouse preosteoblastic cells.[63] (b) Stereolithography - porous poly (D,L-
lactide) for fibroblast culture (c) 3D filamentary printing - multilayered carbohydrate 
glass lattice for sacrificial vascular networks.[7] (Scale bars: a,d, 1mm)  
 
These techniques result in highly controlled 3D architectures, allowing for increased control over 
porosity, orientation, and other features of the microenvironment that can affect cell and tissue 
behavior.   
Colloidal templating of 3D scaffolds begins with the formation of uniform, degradable 
microspheres. Choi et al. used poly(caprolactone)(PCL) spheres, which were formed into a cubic 
close packed lattice and infilled with chitosan, a non-toxic, biocompatible, nanofibrous 
biomaterial.[63]  Upon selective dissolution of the PCL template, a 3D inverse opal structure 
remained in which cells could be seeded and cultured. Stereolithography has been used to create 
matrices with controlled microporosity and stiffness from biodegradable.  A typical flow 
diagram is depicted in Figure 2.8a.  3D scaffolds are designed in CAD and converted to STL 
format for fabrication.  They are produced via UV curing of a photopolymerizable bath.  The 
scaffolds are then cleaned or further processed prior to cell-seeding.  Melchels et al. 
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demonstrated this method with poly (D,L-lactide) (PLDA), a common biodegradable polymer 
used in bone engineering.  3D scaffolds of arbitrary design were constructed with varying pore 
sizes at critical defect sizes of approximately 5 cm x 5 cm x 10 cm (Figure 2.8b).  Mechanical 
properties of the scaffolds can be tuned via microstructure design for specific defect site 
applications. 
 
 
 
Figure 2.8   3D stereolithography for tissue engineering. (a) Process flow for stereolithography.[65] 
(b) CAD designs and built PLDA 5x5x10 mm structures.[3] 
 
 
Recent advances in tissue engineering have focused on scaffold architectures in which the 
biomaterial created by stereolithography[69], inkjet printing[70,71], or 3D printing[8,68,72] and 
pre-seeded with cells (Figure 2.9).  Cell-seeded materials address several limitations of the more 
traditional biodegradable scaffold approach; that finite substrate attachment surfaces are not 
natural mechanisms for tissue growth, that different cell types may need to be placed in 
particular locations for complex tissues, and that vascularization is required in large areas of new 
tissue growth.  
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Figure 2.9.  3D cell printing. (A) Stereolithography - human ASCs in methacrylated gelatin after 
22 days. Oil red O staining indicates intracellular lipid accumulation.[69] (B) Inkjet – 
3D cell “pie.” Blue =  human amniotic fluid-derived stem cells, Red = canine smooth 
muscle cells, Green = bovine aortic endothelial cells. [71](C) 3D printing – 
live(green)/dead(red) staining of rat heart endothelial cells in alginate scaffold after 14 
days.[72]  (scale bars: A, B, 1 mm: C 200 µm) 
 
One novel approach towards this objective is the use of tissue spheroids.[8]  In this 
method (Figure 2.10), cell-laden spheroids are arbitrarily patterned to form desired structures.  
Development from these spheroids produces whole tissue constructs.  Narotte et al. utilized this 
method to form branching vasculature[8].  Chinese Hamster Ovarian cells were distributed in 
agarose molds to form vasculature with a diameter of 900 um within a week.  Heterogeneous 
tissue constructs were formed by placing spheroids of different cell types adjacently. 
 
 
Figure 2.10  Bioprinting of vascular constructs with tissue spheroids. (a) Design template for 
tubular 3D construction. (b) Design template for multi-material tubule. (c) Printed 
human skin fibroblast (HSF) tubule in agarose. (d) Printed HSF branched tubes and 
pattern fusion after 7 days. (e) Cross-section of heterogeneous HSF and human 
umbilical vein smooth muscle cell tubule.[8] 
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2.3.5 HA in 3D Cell and Tissue Engineering 
Because it is a natural, biocompatible, biodegradable polymer with potential for 
functionalization, HA has been a used extensively for cell and tissue engineering.  Seeded, 
crosslinkable gels have been used for growth and proliferation of human embryonic stem cells 
(hESCs) and MSCs.  Gerecht et al. first introduced 3D hESC cultures with methacrylate HA that 
could sustain undifferentiated proliferation of hESCs for 30 days (Figure 2.11).[9]  hESCs 
 
 
Figure 2.11  HA encapsulation of hESCs. Immunofluorescence staining shows expression for (a) 
undifferentiation and (b) HA cellular receptors.  (c) Cells proliferate in culture when 
subjected to various concentrations of unpolymerized polymer prior to 
encapsulation. (d) hESCs form undifferentiated colony morphology 24 hrs after 
release from 30 day encapsulation.[9] (Scale bars: 100µm) 
seeded in HA expressed markers for both undifferentiated proliferation and HA attachment.  
Upon enzymatic release from the hydrogels, hESCs formed colonies with undifferentiated 
morphologies within 24 hours.  Thiolated HA gels previously described were co-polymerized 
with PEG to encapsulate MSCs for myocyte differentiation and repair.  Live/dead staining 
confirmed MSC viability in 3D culture, and the reversible nature of the gel allowed for release of 
cells from the network.[37]   
HA is a key material in cartilage engineering, which is extensively researched as a result 
of a quarter million knee and tendon surgeries every year, nearly all of which have a limited 
lifespan.  HA is popular due to its role as major component of natural articular cartilage, 
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providing much of the compressive strength.  The role of HA role in angiogenesis is also a 
consideration since cartilage is limited in healing capacity due to limited vasculature.[25] Both 
photocrosslinkable [27,28,30] and non-functionalized [73,74] HA have been used, and 
MSCs[73,75] and chondrocytes [28,76] have each been combined with HA to promote 
regeneration of cartilage tissue.  Nettles et al. encapsulated chondrocytes in photocrosslinkable 
HA, and integrated the hydrogels with tissue in osteochondral defects in rabbit models.[28]  
Whole bone and histological images confirmed improved cartilage regeneration in HA trials 
(Figure 2.12), but implanted gels were two orders of magnitude below the compression modulus 
of native tissue.  Hydrogels that evolve due to degradation and cellular uptake in cartilage defects 
with crosslinked HA also showed improved tissue distribution compared to static gels.[77] 
 
 
 
Figure 2.12  Gross (a,b) and histological (c,d) images of filled (a,c) and unfilled (b,d) rabbit    
osteochondral defects.  Green Masson’s trichrome staining indicates deposition of 
collagenous matrix over filled defect.[28]  
 
Patterning of fine-tuned spatial architectures of HA has been limited. Electrospinning[61] 
and layer-by-layer filamentary approaches[22,23] have been utilized, but spanning architectures 
have not been demonstrated like in other bioprinting efforts.  Primitive vascular constructs of 
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cell-seeded HA were printed from a Fab@Home device with NIH 3T3 fibroblasts.  Thiolated HA 
was crosslinked with a 4-armed tetracrylated PEG, and bioprinted cells and features retained 
shaped and viability over 28 days of culture (Figure 2.13 c,d).[23]  A Fab@Home device was 
also used to pattern gold nanoparticle-doped HA and fibroblasts in large tube-like structures 
(Figure 2.13a,b) .[22]  While these methods are integral in their forward progress of cell-seeded 
HA gels, patterning finer features (<200µm) has not been demonstrated to date. 
 
 
Figure 2.13  3D patterning of HA hydrogels. (A) An acellular core I printed in a spiral 
pattern.  Next, the cellularized AuNP-HA is added around the core.  Then, and 
acellular, supportive “halo” is printed. (B) Printed tubular structure without 
acellular supports.[22] (C) Bioprinted thiolated-HA/tetracrylate PEG tubular 
structure printed from filamentary sections.  Green fluorescence indicates 
calcein AM-stained live cells after 28 days of culture [23] (D) Surface view of 
electrospun diydrazide-HA/PEO nanofibrous scaffold.[61] 
 
 
2.3.6 Injectable HA and Injectable Scaffolds 
 
Injectable approaches to 3D tissue engineering are attractive for their potential as 
minimally invasive strategies for regenerative therapy.    Crosslinking of thiolated HA in ambient 
conditions has produced products such as HyStem and Extracel for commercially available, 
injectable HA hydrogels.  Cell encapsulation and injectable HA gels have been investigated for 
repair of damaged cardiac[20], vocal[78], and spinal cord tissues[79].   
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Each of these strategies relies on space-filling, soft gels that lack defined geometry.  
Structural support upon implantation and controlled architecture are not presently available in 
injectable HA systems.  Initial injections are liquid, which requires fine control of gelation, 
making specific placement of hydrogel without spreading difficult. Pre-formed, injectable 
polymer scaffolds offer a solution to such issues.  Bencherif et al. recently addressed this need 
through shape-memory cryogels capable of passage through a standard syringe (Figure 2.14). 
 
 
Fig. 2.14  Preformed, syringe injectable scaffolds. (A) Cryogel before and after syringe injection. 
(B) Arbitrary geometric shape of cryogels. (C) Confocal image of cells (6d incubation post 
injection) in RGD-modified methacrylate-alginate cryogel. (Scale bars: A, 2mm; B, 4mm; 
C, 20 µm).[21]  
 
Encapsulation and cell attachment via methacrylated alginate and an RGD peptide were used to 
load and inject MSCs into mice, where bioluminescent reporter cells were viable and locally 
retained.  Connected macroporosity for injectable cell scaffolds has great potential in tissue 
engineering, and control of porosity and spatial architecture may greatly advance this novel 
approach. 
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2.4 Direct-Write Assembly  
Direct-write assembly is an emerging printing route that enables patterning of 3D 
scaffolds with fine-scale features under ambient conditions.  In this approach, a computer-
controlled, 3-axis translation stage moves an ink deposition nozzle in a layer-by-layer manner to 
produce 3D architectures (Figure 2.15).[80]   By designing ink formulations with appropriate 
rheological properties, a wide variety of materials can be patterned using this printing approach.  
Filamentary features with sizes ranging from 1µm to 1mm can be produced that are capable of 
spanning large gaps, a non-trivial task for other fabrication routes.  
 
 
Figure 2.15  Direct-write assembly. (A) Printing set-up. (i) substrate (ii) print nozzle (iii) 
computer-controlled x-y-z translational air bearing gantry (iv) pressure input (v) 
imaging camera. (B) Schematic of layer-by-layer deposition under UV curing. (C) 
Camera image of printing first layer of hydrogel scaffold through a 30µm nozzle. 
 
To date, a broad array of materials have been printed in arbitrary patterns, including 
hydrogel[5,6], fugitive organic[81-83], colloidal[84-88], polyelectrolyte[89], and nanoparticle 
[90,91,92,93] inks for applications in tissue engineering[5,6,87,88,94], biomimetic design 
[95,96], and self-healing [81-83] materials.  These inks must flow through a fine deposition 
nozzle without clogging, yet quickly solidify to enable patterning of spanning filaments. Hence, 
the ink must be both shear thinning (Figure 2.16a) and viscoelastic, i.e., with a shear elastic 
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modulus (Gʹ) that exceeds the loss modulus (Gʺ) (Figure 2.16b).  The inks typically have a 
viscosity of ~10
1
-10
2
 Pa·s at shear rates relevant for fine scale printing (~20-200 s
-1
)[5].   
 
 
Figure 2.16  Ideal rheology for direct-write inks.  (A) Shear thinning and (B) viscoelastic 
behavior. 
 
Figure 2.17 shows three recent examples of 3D scaffolds patterned by direct-write 
printing guiding fibroblast cell, neuronal cell, and bone growth.  Barry et al. used a 
polyacrylamide hydrogel to fabricate small feature size periodic scaffolds.[5]  3T3 fibroblasts 
seeded onto the scaffolds aligned to parallel feature patterns on 2D surfaces and formed space 
filling morphologies within 3D compartments, while demonstrating interactions with 
neighboring cells.  Direct-write assembly was also used to create 3D poly(2-hydroxyethyl 
methacrylate) (pHEMA) scaffolds for culture of rat hippocampal cells.[6]  Confocal imaging was 
used to identify the optimal scaffold geometry for uniform incorporation of cells during seeding 
as well to characterize the growth and attachment of neuronal processes to these pHEMA 
scaffolds.  3D silk-hydroxyapatite scaffolds were fabricated to support co-cultures of human 
MSCs and human mammary microvascular endothelial cells (hMMECs).[88]  Co-culture is 
required to produce vascular structures in constructed tissue, an important consideration when 
engineering any tissue.  Over six weeks, MSCs and hMMECs remained viable, and osteogenesis 
and angiogenesis markers were both noted.  The promising results to date with 3D scaffolds 
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produced by direct-write assembly  necessitate further investigation of novel materials for 3D 
tissue engineering. 
 
 
Figure 2.17. Direct-write printing of 3D scaffolds for tissue engineering applications. (A) Optical 
fluorescence microscopy image of 3T3 fibroblast seeded on polyacrylamide. 
Rhodamine-phalloidin stains actin red, DAPI stains DNA nucleus blue, and 
fluorescein-o-acrylate stains hydrogel scaffold green.[5] (B) Confocal image of 
primary rat hippocampal cells distributed in 60µm pitch pHEMA scaffold.[6] (C) 
Optical image of HA-silk gradient scaffold.[88] (D) hMMECs on silk-HA scaffold.  
Live cells are stained green.[88] (Scale bars: A, 3mm; C, 50µm; D, 20µm) 
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CHAPTER 3 
 
DIRECT-WRITE ASSEMBLY OF INJECTABLE 3D HYALURONIC 
SCAFFOLDS 
3.1 Introduction 
In this chapter, we create 3D hyaluronic acid-glycidyl methacrylate (HAGM) scaffolds 
via direct-write assembly and demonstrate their potential as injectable platforms in tissue 
engineering.  A novel hydrogel ink composed of HAGM, poly(ethylene glycol) diacrylate 
(PEGDA), solvent and photoinitiator is synthesized, formulated,  and printed to produce 3D 
microperiodic scaffolds that are composed of fine features of <30µm that are retained when 
injected through small microchannels.  HA molecular weight, degree of methacrylation, and 
PEGDA crosslinker as well as printing parameters and scaffold architecture add to the versatility 
and tunability of this system.  Compared to other 3D scaffolds produced for cell culture [5,6], 
our HA ink printing approach produces scaffolds that are highly biocompatible and degradable.   
3.2 Experimental Methods 
3.2.1 Materials 
 Hyaluronic acid (~0.35 and 1.60 x 10
6
 g/mol) is purchased from Lifecore Biomedical.  
Glyicidyl methacrylate (GM), triethylamine (TEA), dimethylformamide (DMF), poly(ethylene 
glycol) diacrylate (PEGDA), poly(3-aminopropyl)triethoxysilane (APTES) and toluidine blue 
are purchased from Sigma-Aldrich and used as received.  Nano-Strip® is purchased from 
Cyantek.  All de-ionized water (DI-H2O) is obtained from a Milli-Q® purification system 
(Millipore).  All other reagents are from central facilities and are of the highest purity possible. 
3.2.2 HA Methacrylation and Characterization 
HA is modified with methacrylate functional groups following a reported method in rthe 
literature[10].  Specifically, HA is dissolved in a phosphate buffered saline (PBS):DMF co-
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solvent (25:75, 50:50 or 75:25, v/v) at 0.5% (w/v) overnight at room temperature.  13.3 g of GM 
and 6.7g of TEA are added drop-wise, and the reaction vessel is stirred for 5-10 days.  The 
solution is precipitated in cold acetone (whose volume is 20 times greater than the volume of the 
reaction solution) and re-dissolved in DI-H2O. The product is dialyzed against DI-H2O for 3 days 
with 2 water changes per day, followed by 3 days of lyophilization.  Hyaluronic acid-glycidyl 
methacrylate (HAGM) is stored at -20°C until further use. 
The degree of methacrylation (DM) iss determined by 
1
H NMR using a Varian Unity 
500.  1% solutions of HAGM in D2O (w/w) are measured at frequency of 500 MHz.  Samples 
are analyzed with NUTS (Acorn NMR) software.  DM is defined as the amount of methacrylate 
groups per HA disaccharide unit and is determined from peak integration ratios between 
methacrylate protons (δ ~6.1 and 5.6ppm) and HA methyl protons (δ ~1.9). 
3.2.3 Ink Design  
HAGM inks are created by combining low (~0.35 x 10
6
 g/mol) and high (~1.60 x 10
6
 
g/mol) MW HAGM of varying DM with PBS/glycerol co-solvent (50:50 w/w), Irgacure 2959, 
PEGDA (average 700 MW), and excess DI-H2O.  A typical ink consists of (w/w) 8.5% low-MW 
HAGM (19.8% DM), 8.5% high-MW HAGM (19.8% DM), 0.1% Irgacure 2959, 8% PEGDA, 
and 74.9% 50:50 (w/w) PBS/glycerol.  Irgacure 2959 is first dissolved in the co-solvent 
overnight.  The photoinitiator and co-solvent, HAGM, PEGDA, and excess DI-H2O (3mL for 5g 
of ink) are combined and mixed for 180s at 2000 rpm (ARE-310, Thinky USA) before being 
magnetically stirred for 12h.  Excess DI-H2O is evaporated at 60°C while mixing with Thinky at 
1h intervals.  As a qualitative measurement, a viable HAGM ink for printing spanning features 
forms a ball (Figure 3.2) immediately following centrifugal mixing. Final ink mixtures are stored 
at room temperature in the dark.  
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Figure 3.1  Optical image of HAGM ink following centrifugal mixing  
3.2.4 Rheological Characterization 
Rheological properties of HAGM inks are measured using a controlled-stress rheometer 
(Bohlin CVOR-200, Malvern Instruments) fitted with cone and plate geometry (CP 4/40, cone 
diameter 40mm, 4° angle, 150 µm gap).  Rheological properties of 5% HA solutions are 
measured with a controlled strain rheometer (AR-G2, TA Instruments) fitted with a concentric 
cylinder geometry.  Viscosity measurements are carried out in controlled shear stress mode 
ascending from shear rates 0.01 to 100 s
-1
.  The elastic shear (G’)  and viscous (G”) moduli are 
measured using an oscillatory logarithmic stress sweep at a frequency of 1 Hz.  All 
measurements are acquired at room temperature with an aqueous solvent trap to mitigate 
evaporation. 
3.2.5 3D Scaffold Printing 
Prior to printing, glass coverslips are cleaned with stabilized sulfuric acid and hyrodgen 
peroxide (Nano-Strip®) at 75°C for 40 min and rinsed with d-H2O.  Slides are dried by blowing  
with compressed nitrogen and further oven dried for 10 min at 125°C.  Cleaned glass coverslips 
28 
 
are placed in a 5% (v/v) solution of APTES in toluene for 12 h at 60°C.  Upon removal, 
coverslips are rinsed with IPA, dried with nitrogen, and stored in the dark at room temperature.  
APTES –coated coverslips promote filament adhesion of HAGM inks via electrostatic attraction 
between negatively charged HA polymer and positively charged amine groups. 
Pre-pulled 10 µm and 30 µm silanized glass pipette tips (World Precision Instruments) 
are sputter-coated with a gold-palladium film (30 nm) (Denton Desk II TSC).  250 µm tapered 
dispensing tips are used as purchased (Nordson EFD). 
HAGM inks are loaded into a 3 mL syringe barrel (Nordson EFD) with an attached tip of 
appropriate size and mounted onto a 3-axis micropositioning stage (ABL9000, Aerotech Inc.) 
controlled by customized software (NView).  Extruded ink filaments are patterned in layer-by-
layer fashion using applied pressures of 10-75 psi (Ultimus 5, Nordson EFD) at a speeds between 
100-1000 µm s
-1
.  During printing, the structures are exposed to UV light with  λ = 320-400nm 
(Omnicure S200, Exfo) at ~10mW cm
2
.  Upon completion of printing, 3D scaffolds are further 
exposed to UV light at ~400 mW cm
2
 for 10 min.  
3.2.6 3D Scaffold Imaging 
Printed HAGM scaffolds are imaged using a SEM (Hitachi S-4700 ) after the samples are 
coated with gold/palladium for 30s (Emitech K575). 
To evaluate scaffold injection that mimics flow through a syringe into a larger cavity (or 
defect site), we created a model microfluidic test cell in a poly(methyl methacrylate) (PMMA) 
block mounted on a CNC-mill (Wabeco V6) and patterned with a 400µm  square-end end mill 
(Performance Micro Tool).  The acrylic blocks with milled microchannels are cut and polished 
on a polishing wheel (EcoMet, Buehler Inc.). Inputs are constructed with a hand drill and 2mm 
tapered tips attached to 3mL syringe barrel (Nordson EFD), and finished channels are mounted 
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onto glass slides with optical adhesive (NOA 78, Norland).  We drill 2mm
2
 and  0.5mm
2
 
channels in PMMA blocks connected by a tapered neck and depositing into a small reservoir 
(Figure 3.2a).  After mounting on a glass slide and installing inputs and outputs, an 8-layer, 
1.5mm x 1.5mm x 0.2mm HAGM-PEGDA scaffold with 30µm filaments is passed through the 
channel.  Applied pressure of 30 psi (Ultimus 5) is used in the forward and reverse directions to 
manipulate scaffolds movements.  Optical images are obtained with an inverted microscope 
(Leica DMI 6000b). Visual depictions of the microchannel design and imaging set-up are shown 
in Figure 3.2. 
 
Figure 3.2 Experimental design for scaffold injection simulation.  (a) Schematic of milled 
channels.  A 2mm
2 
channel tapers into a 0.5 mm
2
 channel that deposits into a 4x4x2mm 
reservoir.  Glass slides were attached to the flat end for optical imaging on an inverted 
microscope (b).  Pressure boxes are attached to inputs and outputs to drive fluid flow. 
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3.2.7 3D Scaffold Degradation 
HA degradability is measured by cutting and obtaining the mass for 3D scaffolds  
(250µm features, 6x6x2 mm) and soaking overnight in PBS.  Scaffolds for each treatment (n=3) 
are placed in a PBS solution with 0, 10, 100, and 1000 U ml
-1
 hyaluronidase at 37°C.  Aliquots 
of these solutions are removed and frozen for further testing and replaced at each time point.  
The concentration of HA degraded is determined using a carbazole assay[97]. 
3.2.8 Mechanical Characterization 
A custom device consisting of a 100g +/- 0.1g load cell (RSP2 Single Point, Loadstar), a 
digital load cell interface (DI-100, Loadstar) and a motorized actuator with 0.2µm repeatable 
incremental accuracy (12mm Z8 Motorized DC Servo Actuator, ThorLabs) is used for collection 
of bulk and scaffold compression data (Figure 3.2a).  The device is calibrated for load cell 
deflection prior to scaffold compression.  5% HAGM in PBS is poured into cylindrical PDMS 
molds (Figure 3.3b) and cured with UV,  λ = 320-400nm (Omnicure S200, Exfo) at ~400mW 
cm
2
 for 10 min.  Samples (Figure 3.3c) (n=3) are tested in a single pass, uniaxial, unconfined 
compression at 50µm s
-1
, and data collected by LabVUE.  Moduli are taken by fitting data from 
5%-10% strain. 
Printed HAGM-PEGDA scaffolds with 250µm filaments (n=3) are pre-soaked in PBS for 
24 h and tested in a single pass, uniaxial, unconfined compression immediately after removal 
from media.  Scaffolds are compressed at 50µm s
-1
, and data is collected by LabVUE.  Moduli 
are taken from 30g-60g loads in the linear regime,  corresponding to strains of approximately 
5%-10%. 
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Figure 3.3  Mechanical characterization of HAGM. (a) Custom device for mechanical 
compression testing, including the (i) load cell, (ii) digital load cell interface, (iii) 
motorized actuator, and (iv) sample location and alignment prism. (b) PDMS mold 
formed with 5mm biopsy punch. (c) Completed sample for mechanical 
characterization. (scale bars: b,c, 5mm) 
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3.3 Results and Discussion 
Direct-write assembly is a process by which 3D architectures are patterned by extruding 
ink filaments in a layer-by-layer fashion using a 3-axis computer controlled stage (Figure 3.3).   
 
Figure 3.4  Direct-writing of 12 mm HAGM scaffold with 250 µm filaments under UV light. (a)  
Optical zoom camera (b)Mounting block for syringe barrel connected to air pressure 
line (c) Attachment point to x-y-z positioning stage (d) 250µm nozzle.  Inset: 
schematic of layer-by-layer filamentary deposition during the direct-write process. 
 
Inks suitable for 3D printing must flow through fine nozzles, yet undergo rapid solidification 
upon deposition in order to retain their filamentary shape and span gap(s) across underlying.  To 
promote the desired solidification, hyaluronic acid (HA) is modified with photo-reactive glycidyl 
methacrylate (GM) functional groups via a ring-opening mechanism.  By varying reaction 
conditions (Table 3.1), we functionalized the polymer backbone with GM at 8.2%, 19.8%, and 
29.8% (± 3.6%) degrees of methacrylation (DM), determined from NMR peak integration ratios 
between methacrylate protons (δ ~6.1 and 5.6ppm) and HA methyl protons (δ ~1.9) (Figure 3.5, 
peaks a,b).  DM represents the amount of methacrylate groups per HA disaccharide unit (Figure 
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3.5).  Decreasing the ratio of PBS:DMF or  increasing the molar ration of HA:GM leads to 
increases in the DM (Table 3.1).  The respective compressive moduli of cured 5% HAGM 
hydrogels increase with DM (8.2%, 19.8%, and 29.8%).  Values of 18.5 ± 1.3 kPa, 54.5 ± 1.4 
kPa, and 80.8 ± 1.5 kPa are observed as shown in the inset of Figure 3.5.  The scaffold stiffness 
is influenced by both the DM content as well as its 3D geometry. 
 
Table 3.1 Reaction conditions for HA methacrylation. 
 
Figure 3.5  Methacrylation of hyaluronic acid. H
1
-NMR spectroscopy of HAGM polymers.  
Proton peaks at (a) and (b) indicate methacrylate functionalization, calculated at 8.2%, 
19.7%, and 29.8%.  Inset depicts increasing load vs displacement fits for 5% cured 
hydrogels of the three DMs. 
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Direct-writing of HAGM inks requires a material that flows during nozzle extrusion, yet 
is solid-like to prevent feature sagging prior to UV curing.  We must first design a DM HAGM 
ink that meets this requirement.  The apparent viscosity as a function of shear ratefor 5% 
solutions of each synthesized DM HAGM is shown in Figure 3.6.   
 
Figure 3.6  Ink viscosity as a function of shear rate of 5% HAGM solutions in PBS at 3 degrees of     
methacrylation. 
 
At equivalent polymer concentrations and shear rates, the ink viscosity increases as DM 
decreases, varying by 2 orders of magnitude at 0.01 s
-1
 shear rate from 94.27 Pa·s for 29.8%DM 
to 0.24 Pa·s for 8.2% DM.  To achieve homogenous inks at polymer concentrations high enough 
to support spanning features, excess water is added to the initial ink formulation to fully dissolve 
the hydrogel, which is subsequently evaporated.  Because of low solution viscosity observed for 
higher DM concentrats, inks formulated from 29.8% DM HAGM require more water to be 
evaporated to enhance their concentrations above 5%.  However, we found that more 
concentrated polymer solutions undergo premature curing. Thus, we opted not to design 
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printable inks composed of 29.8% DM HAGM inks.  Fortunately, premature curing was not 
observed for the 8.2% and 19.8% DM HAGM solutions, so we used these materials to produce 
printable hydrogel inks.  We determined an optimal total polymer concentration for 19.8% and 
8.2% DM HAGM inks of 17.0% and 14.2% (w:w), respectively, with a 1:1 ratio of high:low 
MW HAGM.   Both formulations exhibit shear thinning behavior (Figure 3.7a) that arises from 
physical entanglement of HA polymer chains, with shear thinning exponents n~0.10 according to 
the power law η  n-1, where η is the solution viscosity and    is the shear rate. 
 
Figure 3.7 Rheological behavior of HAGM ink at two degrees of methacrylation (8.2% and 
19.7%). (a) Ink viscosity as a function of shear rate. (b) Ink shear elastic (G’) and 
viscous (G”) moduli measured in oscillatory mode at 1 Hz. 
 
Shear rate experienced by the ink at the nozzle walls during printing can be estimated by:  
  wall =  
   
 
 
  
    
where b is the inverse of the shear thinning exponent, n, Q is the volumetric flow rate (=vπR2), v 
is the print speed, and R is the nozzle radius.[6]  It is determined using b= 0.9 and an average 
print speed of 1mm·s
-1
 that the shear rates during nozzle deposition are ~390s
-1
 for 10µm 
nozzles, our smallest used, and ~15.6s
-1
 for 250µm nozzles, our largest used.  Even at the largest 
nozzle size and lowest associated shear rate, both inks exhibit viscosities of ~20 Pa·s, nearly two 
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orders of magnitude below low shear viscosities at 0.1 s
-1 
of 1618.90 (8.2% DM) and 1842.50 
(19.8% DM) Pa·s.  The dramatic reduction under relevant printing conditions ensures ink 
deposition without clogging.   
The shear elastic modulus is another critical rheological parameter for the synthesis and 
design of these inks; it is a key parameter that determines the ability of the printed material to 
span gaps across underlying layers during 3D fabrication.  The elastic moduli (Gʹ) of the 8.2% 
DM HAGM(~8 kPa) and  19.8% DM HAGM (~7 kPa) are both higher than their respective loss 
moduli (Gʺ) of ~4kPa and ~5kPa (Figure 3.7b).  This solid-like behavior is a hallmark of inks 
capable of patterning spanning filaments.  To ensure that spanning features are maintained 
beyond printing times of 5 min, when feature sagging can occur, extruded filaments are exposed 
to UV light during printing.  Cross-linking of the methacrylate groups functionalized on the 
polymer backbone form 3D features that are maintained for months beyond the printing window.  
3D scaffolds are printed using this method with 10µm (Figure 3d;), 30µm (Figures 3a-c) and 
250µm (Fig 3.8a) filaments. Filament spacing can also be modified, with filament diameter-to-
filament spacing ratios ranging from 2:1 (Figures 3.8a,b,d) to 8:1 (Figure 3.8c).  Because the 
same materials system is used in all structures, the features are simply altered by changing nozzle 
size and/or computer code that controls the printhead.  
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Figure 3.8 SEM micrographs of printed HAGM scaffolds. (a) Low and (b) higher magnification 
images of 6-layer HAGM scaffolds printed with 30µm and 2:1 edge-to-edge 
spacing:filament diameter ratio.  Printing parameters can be varied by adjusting the 
spacing (c) 30µm nozzle, 8:1 ratio or the nozzle diameter (d) 10µm nozzle, 2:1 ratio. 
(scale bars: a, 400µm; b-d, 100µm) 
 
The effect of scaffold geometry on compressive modulus is shown in Figure 3.9.   
HAGM-PEGDA scaffolds are printed with a 250µm nozzle with center-to-center filament 
spacings of 750µm, 1250µm and 1750µm (Figures 3.9a i-iii).  The compressive moduli of 
scaffolds (n=3) under unconstrained, uniaxial compression decreases from 584 ± 81 kPa to 155 ± 
4 kPa as center-to-center filament spacing increases from 750 µm to 1750 µm (Figure 3.9b).  For 
tissue engineering applications, HAGM-PEGDA scaffolds can be arbitrarily printed with feature 
sizes that produce compressive moduli matching the desired characteristics of surrounding tissue.  
Articular cartilage, for instance, is a commonly targeted load-bearing tissue for regenerative 
therapies that has a compressive modulus of approximately 600 kPa, which is akin to that 
observed for HAGM-PEGDA scaffold with a 750µm spacings.  This feature size is therefore 
applicable to cartilage replacement implantations in load-bearing sites that require matching 
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compressive moduli to surrounding tissue.  A library of feature sizes for 3D printed HAGM and 
HAGM-PEGDA scaffolds could be developed to complement other tissues.  The maximum 
modulus achievable is 5.93 ± 1.13 MPa, which corresponds to the compressive modulus of the 
printed HAGM-PEGDA filament value.  This is well below relevant values for bone repair 
which must withstand high compressive loads, but lies within range of articular cartilage, 
muscle, tendon, and ligament. 
 
Figure 3.9  Effect of 3D scaffold structure on compressive modulus. (a) Optical images of 
scaffolds printed with center-to-center spacings of i) 750µm, ii) 1250µm, and  iii) 
1750µm. (b) Compressive moduli decreases with increasing center-to-center spacing. 
(scale bar, 1mm) 
 
Direct imaging of a 3D HAGM scaffold flowing through micro-machined tapered 
channel is carried out to simulate scaffold injection for minimally invasive implantation 
applications, such as arthroscopic surgery.  An 8-layer, 1.5 mm x 1.5 mm x 0.2 mm HAGM-
PEGDA scaffold composed of 30µm filaments is flowed through a tapered microchannel whose 
dimensions change from 2 mm
 
x 2 mm to 0.5 mm x 0.5 mm, a 16-fold reduction, without 
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damage to the microperiodic structure (Figure 3.10b).  The smallest dimension through which 
the 3D scaffold must pass through is one-third of its lateral size.  By using glycerol as the 
flowing media, we slowed down scaffold movement through the channel so that we could 
directly capture evidence of the rolling mechanism of the scaffold through the taper and small 
channel region before its shape is restored to the original configuration as it enters the large 
cavity (4 mm x 4mm x 2mm) (Figure 3.10c) .  Their mechanical robustness also permits them to 
be stamped from larger printed sheets for potential commercial scale-up (Figure 3.11). 
 
Figure 3.10  Injectable HAGM scaffolds. (a) Channels tapering from 2mm
2
 down to 0.5mm
2
 
formed out of PMMA with a CNC mill. (b) Optical image of 8-layer 1.5x1.5x0.2mm 
HAGM scaffold before (left) and after (right) passing through tapered channel. (c) 
Frame-by-frame shots of scaffold passing through tapered channel by fluid flow. 
(scale bars: b, 0.5mm; c, 4mm) 
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Figure 3.11  Demonstration of scaffold stamping for commercial scale-up applicaitons.  Multiple 
scaffolds printed in one session (a) can be stamped with a biopsy punch (b) to well 
defined scaffold geometries (c) with clean cut edges (d).  Arbitrarily large scaffold 
sheets and stamping mechanism could be used for large-scale fabrication. (scale 
bars: a,b 5mm; c, 1.5mm; d, 500µm) 
 
A desirable feature of implanted scaffolds in tissue engineering is biodegradability as 
cells and tissues of the body infiltrate and proliferate to fill a target defect.  HA scaffolds benefit 
from natural degradation when exposed to hyaluronidase (HAase) in vivo by cleavage of the β-
N-acetylhexosamine-[1→4] glycosidic bonds.  To evaluate this feature, both HAGM and 
HAGM-PEGDA scaffolds are placed in PBS solutions of varying HAase concentrations ranging 
from 0-1000 U/mL over the course of 21 days, with media changes to supply fresh HAase at 
each time point (Figure 3.12).  HAGM scaffolds degrade faster than HAGM-PEGDA scaffolds 
due to decreased crosslinking in the hydrogel.  Depending on target applications, direct-write 
printed scaffolds may be tailored to degrade at specific rates by varying PEGDA concentration 
from 8% (Figure 3.12a) to 0% (Figure 3.12b). 
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Figure 3.12  Scaffold degradation of (a) HAGM-PEGDA and (b) HAGM scaffolds in HAase 
solutions over 21 days. 
 
3.4 Conclusions 
We demonstrated the ability to fabricate 3D hydrogel scaffolds by direct-writing of 
HAGM, a naturally derived, biocompatible, biodegradeable polymer modified with UV-curable 
functional groups.  Tunability of the HAGM scaffolds toward specific applications and material 
properties were established by variations in polymer DM and MW, scaffold feature size, and 
PEGDA concentration.  Finally, the ability of the scaffolds to undergo compression through 
small channels without suffering structural damage showed potential for injection-based tissue 
engineering strategies. 
 
 
 
 
 
 
 
 
42 
 
CHAPTER 4 
CELL CULTURE AND TISSUE ENGINEERING APPLICATIONS OF  
3D HYALURONIC SCAFFOLDS 
4.1 Introduction 
 In this chapter, we utilize printed HAGM-PEGDA scaffolds in in vitro and in vivo 3D 
cell culture and tissue engineering applications.  Adipose derived stem (ASCs) are cultured on 
these 3D scaffolds as well as 2D controls to investigate cartilage formation.  By coupling an 
RGD peptide to the scaffolds, their cell binding is enhanced, promoting infiltration of developing 
cartilage.  A strategy for infusing HAGM-PEGDA scaffolds with a cell-laden, dilute HAGM gel 
is explored to evenly distribute these cells throughout these 3D structures.  Cell proliferation and 
mobility are observed, and cartilage formation is positively identified through a quantifiable 
assay and immunohistochemistry.  Finally, an initial attempt at HAGM-PEGDA scaffold 
implantation in a live porcine model is discussed, and the biocompatibility and tissue growth in 
defect sites are demonstrated. 
4.2 Experimental Methods 
4.2.1 Materials 
            Primary antibodies for aggrecan and collagen II are obtained from Novus Biologicals 
(CN# NBP2-12447) and Millipore (CN# MAB1330), respectively.   Texas Red secondary 
antibody is purchased from Vector Labs (TI-2000).  Cyanoacrylate tissue adhesive is obtained 
from Vet-Bond.  Pig analgesic is purchased from Banamine and antibiotic from Excede.  Arg-
Gly-Asp-Cys (RGDS) was obtained from Genscript. TGF-β1, 50 nM ascorbic acid-2-phosphate, 
hyaluronidase, toluidine blue, papain, ethylenediaminetetraacetic acid (EDTA), dithiotriol 
(DTT), chondroitan sulfate from shark cartilage, dimethylmethylene blue (DMMB), and Triton 
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X-100 are from Sigma-Aldrich. All other reagents are from central storeroom facilities and are of 
the highest purity possible. 
4.2.2 RGD Scaffold Fabrication 
To create inks containing cell-binding peptides, RGDC and PEGDA are dissolved in 
0.1% Irgacure 2959 (w/w) in PBS for 4 h at room temperature with mechanical mixing at a 10:1 
molar ratio of acrylate to thiol functional groups according to prior work[16]. HAGM, glycerol, 
and excess water are added and the ink synthesis (section 3.2.4) and printing (section 3.2.5) 
proceeds as previously described. 
4.2.3 In Vitro Cell Culture 
Details on porcine adipose-derived stem cell (ASC) primary culture are as previously 
reported.[98]  All protocols are approved by the University of Illinois Institutional Animal Care 
and Use Committee (IACUC). Frozen ASCs are thawed and plated (passage 2-3) at a density of 
7.5 × 10
5
 cells/mL. Cells are cultured to 80% confluency before trypsinization and plating onto 
scaffolds. Differentiation is induced by culturing cells in a micromass culture as previously 
described.[99]  Ten-microliter drops containing 5 X 10
5
 cells in media supplemented with 1% 
FBS containing transforming growth factor (TGF-β1, 10 ng/ml) are placed on scaffolds and 
incubated for 1 h before filling wells with chondrogenic media. Chondrogenic differentiation 
medium consisted of basic high-glucose DMEM supplemented with 10 ng/mL TGF-β1 (Sigma 
T7039), 50 nM ascorbic acid-2-phosphate (Sigma A4403), 1% FBS, 1% penicillin G-
streptomycin, and 5.6 mg/L of amphotericin B. The cells are maintained in chondrogenic 
medium for 2 weeks with medium changed every 3 days. 
Green Fluorescent Protein (GFP)-positive ASCs at a concentration of 3x10
6
 cells/mL are 
encapsulated in 2% HAGM-PEGDA in DMEM gels in 125µl aliquots per 96 plate well.  Cells 
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isolated from a pig transgenic for GFP[100] are cultured for 7 days and imaged with an inverted 
fluorescence microscope (IX71, Olypmus).   Micromass culture and high density seeded 
encapsulation are conducted according to previously published experimental 
procedures.[101,102] Culture expanded ADSCs are harvested and pelleted in DMEM.  For HA 
encapsulation treatments (n=3), cells are re-suspended in 2% HAGM-PEGDA in chondrogenic 
media at 2x10
7
 cells/mL.  Positive controls (n=3) are re-suspended in chondrogenic media at 
2x10
7
 cells/mL.  Negative controls (n=2) are re-suspended in DMEM with 1% FBS containing 
transforming growth factor (TGF-β1, 10 ng/ml).  Droplets of 12.5 µl of each treatment are 
pipetted into 24 well plates and incubated for 2 hours at 37°C and 5% CO2.  Following 
incubation, 500µl of solution relevant to each treatment is added in each well, and cells are 
cultured at 37°C and 5% CO2. Cells are maintained in media for 11 days with media changes 
every 2 days. 
4.2.4 Mechanical Characterization 
Compression moduli of 2% bulk HAGM in PBS and HAGM-PEGDA scaffolds are 
obtained with the custom device described previously.  3D scaffolds (10mm in diameter) of 8-
layers with 250 µm filaments spaced 750µm center-to-center are printed and cured with UV 
light,  λ = 320-400nm (Omnicure S200, Exfo) at ~400mW cm2 for 10 minutes and injected with 
2% HAGM in PBS before curing again.  All samples (n=3) are soaked for 24 hours in PBS 
4.2.5 Cell Imaging 
 For immunohistochemistry (IHC), cell aggregates are collected, frozen in optimum 
cutting temperature (OCT) embedding compound, and stored at -80°C.  Frozen blocks are cut 
into 10µm sections (Cm1900, Leica), mounted on glass slides, and stored at -80°C.  Sections are 
fixed in cold acetone for 10 mins before bringing to room temperature.  Slides are incubated in 
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5% horse serum in PBS containing 1% Triton X-100 (PBS-T) to block binding of nonspecific 
antibodies for 30 minutes, washed with 1% horse serum in PBS-T, and incubated with primary 
antibodies for aggrecan and collagen II (50:1 in 1% serum PBS-T) at 4°C overnight.  Sections 
are washed with 1% serum PBS-T and incubated with 15µg/mL Texas Red secondary antibody 
in 1% serum PBS-T for 1 hour at room temperature.  Sections are washed with 1% serum PBS-
T, mounted, and imaged with an inverted fluorescence microscope (DMI 4000, Leica).   
4.2.6 Bulk HA Degradation 
 Aliquots of HAGM containing 1333µg and 2667µg of polymer are put in 24 well plates 
and are cured with UV,  λ = 320-400nm (Omnicure S200, Exfo) at ~400mW cm2 for 10 minutes.  
After soaking for 24 hours in PBS, 1mL of 1000 U/mL hyaluronidase is added, and samples are 
incubated for 48 hours at 37°C. HA concentrations are determined using a carbazole assay.[97] 
4.2.7 s-GAG Quantification  
 Sulfonated glycosaminoglycan (s-GAG) content is determined by a DMMB 
assay.[75,103]  After 4, 7, and 11 days, 3D chondrogenic cultures are removed and digested with 
papain for 48 hours at 60°C.  Papain solution is prepared at 300µg/mL papain in 20mM sodium 
phosphate buffer (pH=6.8) containing 1 mM EDTA and 2 mM DTT.  Following digestion, 2.5 
mL DMMB solution is added to 100µl of the sample, and the absorbance at 525 is determined 
with a microplate reader (SpectraMax, Molecular Devices).  DMMB solution is prepared by 
adding 16 mg DMMB, 3.04 g glycine, 2.37g NaCl, and 95 mL of 0.1M HCl to 1L distilled 
water.  Chondroitan sulfate is used as a standard to provide a calibration fit. 
4.2.8 In Vivo Scaffold Implantation 
Prior to surgery, printed  HA-PEGDA scaffolds (8 layer, 250µm nozzle, 750µm center-
to-center spacing) are pre-swelled to 10mm diameter and 2 mm thickness.  The pig is prepped 
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for surgery by shaving and sterilizing the lower jaw, followed by application of iodine and 
thyroid drapes.  A scalpel and electrocautery pencil are used to penetrate fat and muscle, and 
periosteum is removed with a periosteal elevator (Figure 4.1a).   Ten mm transcortial 
osteotomies (4 per side) are performed with a trephine on the posterior region of the mandible 
with adequate irrigation  [104,105], and scaffolds are placed in 2 osteotomies on each side 
(Figures 4.1 b,c).  In the left mandible, scaffolds were secured with a cell-laden, fibrin and blood 
mixture.  Blood is collected from the ear vein and mixed with 1 mL of cell/DMEM solution to a 
total volume of 5mL.  After quick mixing, the solution is immediately injected into the defect 
and combined with 0.1 mL of 0.3M calcium hydrogen phosphate to induce coagulation.  Empty 
controls are also treated with the fibrin and cell mixture.  In the right mandible, scaffolds are 
secured with tissue adhesive.  The periostium, muscle, fat, and skin layers are sutured, and the 
wound is closed with tissue adhesive.  Pigs are administered an analgesic and antibiotic and 
allowed to recover. Pigs are maintained on a soft diet for 1-3 days post-surgery and then resume 
standard feed. 
 
Figure 4.1 Implantation of HAGM-PEGDA scaffolds in a pig mandible. (a) Exposure of the 
mandible. (b) 10mm defects formed with a trephine. (c) HAGM-PEGDA scaffolds 
implanted in defects 
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4.2.9 Computed Tomography  
 At 3 and 7 weeks post-surgery, the jaw region of the pig is scanned using computed 
tomography (CT) (Lightspeed 16 Slice, GE Medical Systems) at 120kV and 64 mA.  3D 
rendering of CT slices is accomplished using Carestream. 
 At 12 weeks post-surgery, the pig mandible is harvested and the defects are separated and 
trimmed with a band saw. After 2 weeks in pure ethanol, the remaining soft tissue is removed to 
expose defect sites.  Micro-computed tomography (Micro-CT) conducted at 100 kV and 100 mA 
with a copper-aluminum filter is used to image bone defects every 0.7° for 360°. (Skyscan 1172, 
Bruker).   3D modeling of the 2D slices is accomplished via a reconstruction algorithm (NRecon 
1.1.4) and rendering (Amira 5.0). 
4.2.10 Bone Mineral Density 
 Bone mineral density (BMD) for bone growth within the defect area is measured using 
dual energy x-ray absorptiometry (DXA) (QDR 4500A, Hologic).  BMD, given in g/cm
3
, is 
determined by absorption differential between two x-ray beams of different energy levels.  Due 
to dependence on sample thickness, BMD is normalized against whole bone surrounding defect 
of similar thickness and is presented as defect BMD/non-defect BMD. 
4.3 Results and Discussion 
As an initial test for applications with cartilage tissue, HAGM-PEGDA scaffolds are 
seeded with ASCs and pushed towards chondrogenic differentiation.  Toluidine blue stains 
purple for glycosaminoglycans, a primary component of cartilage, and is known as a positive 
indicator for cartilage.[106]  After 14 days, cartilage from cells seeded on 6-layer HAGM-
PEGDA scaffolds demonstrate a more distributed morphology compared to 2D controls (Figure 
4.2a-b).  Scanning electron microscopy is used to examine the 3D distribution of cartilage.  
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Cartilage formation on HAGM-PEGDA scaffolds was minimal, and the most significant 
development occurred in cartilage growths on the underside of the scaffold (Figure 4.2c).  To 
resolve this issue, cell-binding RGD was incorporated with PEGDA via a Michael’s addition 
prior to mixing with the other ink components.  The peptide promotes cartilage growth that was 
more evenly spread throughout and within the microperiodic architecture (Figure 4.2d).   
 
 
Figure 4.2 Scaffolds effects on cartilage morphology.  Cartilage stained with toluidine blue after 
14 days on (a) polystyrene culture plate and (b) polystyrene culture plate with HAGM 
scaffold.  SEM micrographs of cartilage on scaffolds without (c) and with (d) an 
incorporated RGD peptide. (scale bars: a,b, 75µm; c,d, 50µm) 
 
 
Though cartilage was found to better infiltrate the 3D architecture with the incorporation of 
RGD, even distribution of ASCs is difficult during initial seeding, and cells tend to aggregate or 
fall to the bottom of the scaffold.  These phenomena lead to pockets of cartilage rather than 
tissue growth over the entire scaffold. 
 A strategy for evenly distributed cell seeding is the use of hydrogels as a biocompatible, 
cell-seeded matrix for cell proliferation, tissue formation, and growth.  We use 2% HAGM as our 
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cell-seeded hydrogel, the same polymer that serves as the primary material component for the 
hydrogel direct-write ink previously discussed.  For tissue engineering applications, it is 
desirable to match the tissue implant to surrounding, native tissue.  After UV curing, 2% HAGM 
has a weak compressive modulus of 9.1 +/- 0.8 kPa compared to native cartilage at 
approximately 600 kPa (Table 4.1). [28]  
 
Table 4.1  Compressive moduli of scaffolds and bulk HAGM 
 
 
HA scaffolds have a compressive modulus that lies within the range of native cartilage  
(~600 kPa).  Compressive moduli of scaffolds infused with 2% HAGM are similar to the pure 
scaffoleds.  By infusing 3D HAGM-PEGDA scaffolds with cell-seeded HAGM, it is possible to 
have cell distribution throughout the entire scaffold and robust compression mechanics to 
emulate surrounding native cartilage. 
 Cell viability and 3D distribution are necessary features of a cell-laden hydrogel system 
and are confirmed by imaging ASCs in a 2% HAGM gel and monitoring GFP fluorescence. 
Cells cultured on 2D well plate controls are only visible on plane of focus and tend to cluster 
(Figure 4.3a), while cells in 2% HAGM are more evenly dispersed and visible at all Z focal 
planes throughout the 2mm thick sample (Figure 4.3b-d). 
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Figure 4.3 Optical images of ASCs distributed in 2D and 3D.  (a) ASCs cultured on polystyrene 
culture flask. (b-d) ASCs in 2% HAGM gel imaged in three different focal planes. 
(scale bars: 500µm) 
 
 
Cells cultured in 2% are GFP-positive, fluorescent at 510nm, and used to positively confirm cell 
viability.  Cells are viable over the course of 6 days of culture in the 2% HAGM gel, and 
increases in cell density demonstrate proliferation between days 3 and 6 (Figures 4.4 a,b).  Cells 
clusters are also found within the samples after 6 days that are not present at day 0, confirming 
cell mobility within the hydrogel (Figure 4.4c).   
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Figure 4.4 Bright field (top) and fluorescence (bottom) images of GFP-positive ASCs cultured in 
2% HAGM at (a) 3 and (b,c) 6 days. (scale bars: 200µm) 
 
This cell mobility is very important, as cell-cell interactions promote N-cadherin, a molecule 
involved in chondrogenesis.[107]  Cluster formation increases the number of cell-cell 
interactions and enhances cartilage development.[108] 
Encapsulating materials for tissue engineering applications must be biodegradable, 
breaking down as new tissue grows to fill defect sites.  The ability of the 2% bulk HAGM to 
degrade is confirmed by measuring glycosaminoglycan (GAG) content before and after 
incubation of the cured hydrogel with hyaluronidase (HAase), a naturally occurring enzyme that 
cleaves cleavage the β-N-acetylhexosamine-[1→4] glycosidic bonds of HA (Table 4.2)  
 
Table 4.2  Comparison of initial sample GAG content and experimentally observed GAG content 
in solution after exposure to HAase 
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In aliquots of UV cured  HAGM containing 2667 µg/mL and 1333 µg/mL of polymer (HA is a 
GAG), near equivalent amounts of GAGs are detected in solution after 48 hours incubation with 
HAase.  All of the cured polymer degrades into solution, while much smaller concentrations are 
detected when HAase is not present.  If implanted in vivo, HAGM encapsulating ASCs would be 
biodegradable due to the presence of HAase in body fluids. 
 To confirm chondrogenic differentiation in HA hydrogels and the formation of cartilage 
tissue, ASCs are cultured in densely seeded micromasses, which are optimal because they best 
mimic pre-chondrogenic cellular condensation in vivo.[101,109]  Over the course of 11 days in 
culture,  the sulfated glycosaminoglycan (s-GAG) content rises for ASCs cultured in HAGM gel 
as well as for ASCs cultured under standard micromass conditions (positive control) (Figure 
4.5). 
 
Figure 4.5 s-GAG content in densely seeded ASC cultures over 11 days 
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 s-GAGs are a primary matrix element of cartilage and indicate chondrogenic 
differentiation.[110] s-GAG content in ASCs in HAGM without chondrogenic media, the 
negative control, stay well below both the treatment and positive control over 11 days.  There is 
no data point at Day 0 for the positive control, because there is no cell attachment immediately 
after plating.  Error bars are high for early time points in Figure 4.5, which may be reduced in 
future experiments with increased protocol practice and sample size. After 11 days, 
immunohistochemistry (IHC) of the cultured aggregates is used to identify the presence of type 
II collagen, the predominant collagen fiber, and aggrecan, the predominant proteoglycan in 
cartilage tissue.  Expression of collagen II and aggrecan in IHC is a visual confirmation of 
chondrogenic differentiation.  ASCs cultured in HAGM (Figures 4.6c,d) and in the positive 
control (Figure 4.6a,b) both express fluorescence from antibodies stained against collagen II and 
aggrecan.  No cell clusters are formed for adequate IHC staining in the negative controls. 
 
Figure 4.6 IHC of cultured aggregates from ASCs cultured with chondrogenic media (a,b) and 
ASCs seeded in HA and cultured in chondrogenic media (c,d).  Fluorescence is from 
Texas Red secondary antibodies bound to primary antibodies for (a,c) type II collagen 
and (b,d) aggrecan. (scale bars: 200µm) 
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The presence of aggrecan and collagen II and the increase in s-GAGs over 11 days of culture 
demonstrate that ASCs are undergoing chondrogenesis while cultured in high cell density (2x10
7
 
cells/mL) and that cartilage tissue is forming. Since the ASCs can be evenly distributed within 
degradable HAGM gels and HAGM-PEGDA scaffolds have a compressive modulus near that of 
native articular cartilage, a reasonable next step is the implantation of infused HAGM scaffolds 
in an in vivo model. 
 Prior to implantation in articular cartilage sites, we sought to confirm the biocompatible 
nature of the printed scaffolds and the ability to promote tissue growth in porcine mandibular 
bone defects, a simpler and more practiced procedure for our collaborators (Wheeler group) in 
Animal Sciences at UIUC.  Both scaffold treatments and controls in 10mm defects on one 
mandible are treated with ASCs because of their demonstrated ability to promote increased 
levels of bone formation.[111]  The pig experiences no adverse effects or setbacks from the 
implanted scaffolds during the 12 week period and is able to resume consumption of soft foods 
after just 24 hours.  Computed tomography (CT) scans of the pig at 3 and 7 weeks show bone 
growth in the  defects during the 4 week period (Figure 4.7), but no significant difference are 
noted between ASC treated (Figures 4.7 a,c) and non-ASC treated (Figures 4.7 b,d) defects.   
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Figure 4.7 Computed tomography (CT) scans of pig containing mandibles with implanted 
HAGM-PEGDA scaffolds at (a,b) 3 and (c,d) 7 weeks.  (a,c) Left mandible contains 
defects treated with ASCs.  (b,d)  Right mandible defects had no ASCs.  
 
When the mandibles are harvested after 12 weeks, micro-CT scans are possible on cut 
defects.  Two defects experienced excellent healing, showing complete infilling of bone within 
the 10mm defect (Figures 4.8 a,d).  No negative controls without scaffolds completely healed 
(Figures 4.8 c,f), though two negative controls were rejected from the results analysis, because 
they were drilled too far into the marrow space of the mandible.  The stem cell rich environment 
of the marrow space and the widely varied structure of the bone in this region do not permit 
logical comparisons to be made to other defect sites.  In two of the defects with scaffold 
treatments, bone formation was present, but complete healing did not occur (Figures 4.8 b,e).  No 
significant differences between ASC treated (Figures 4.8 a-c) and non-ASC treated (Figures 4.8 
d-f) can be determined from the micro-CT scans. 
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Figure 4.8 Micro-CT scans of bone defect sites after 12 weeks. (a-c) Defects with ASCs and (d-f) 
defects without ASCs. (a,b,d,e) Scaffold treated defects and (c,f) non-scaffold treated 
defects.  Red arrows indicate initial defect location. 
 
Bone growth in defect sites is quantified by bone mineral density (BMD) with dual 
energy x-ray absorptiometry (DXA).  Representative DXA scans of a well healed (Figure 4.9a, 
top) and poorly healed (Figure 4.9b, bottom) are given, and surrounding healthy bone is used to 
produce a normalized BMD.  Defects in which scaffolds are implanted have higher normalized 
BMDs (0.70 +/- 0.12 and 0.68 +/1 0.16) than non-scaffold treated defects (0.54 and 0.58) (Figure 
3.9).  Due to low sample size (n=2) and one defect in each non-scaffold treatment being removed 
from the analysis, no errors can be calculated for treatments without scaffolds.  No significant 
differences are found between ASC and non-ASC treated defects.  Increasing the number of pigs 
for future experiments will allow for increased statistical power and analysis. 
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Figure 4.9 DXA of bone defect sites after 12 weeks. (a) Representative images of well healed 
(top) and poorly healed (b) defects.  (b) Normalized bone mineral densities (BMD) of 
defect sites. 
 
4.4 Conclusions 
             We demonstrated the formation of cartilage on HAGM-PEGDA scaffolds seeded with 
ASCs pushed towards chondrogenic differentiation.   Cartilage had more spread out 
morphologies on scaffolds versus controls and was able to best infiltrate scaffolds with the 
incorporation of an RGD peptide.  The possibility of infusing scaffolds with cells encapsulated in 
a dilute HAGM hydrogel was explored for tissue engineering applications.  Compressive moduli 
of printed HAGM-PEGDA scaffolds containing 2% HAGM nearly match that of native articular 
cartilage, and cells encapsulated in the HAGM were distributed evenly in 3D and underwent 
chondrogenesis to form cartilage tissue.  HAGM-PEGDA scaffolds were implanted in vivo in a 
porcine model, were biocompatible, and permitted bone growth in defects.  This initial in vivo 
experiment coupled with confirmed cartilage growth in HAGM to be used for encapsulation are 
promising preliminary findings and point to the need for future articular cartilage tissue 
regeneration experiments with cell infused HAGM scaffolds. 
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CHAPTER 5 
CONCLUSIONS 
 3D scaffolds composed of hyaluronic acid, a natural, biocompatible, and biodegradable 
polysaccharide, were created using direct write-assembly for cell culture and tissue engineering 
applications.   The mechanical properties of HAGM and HAGM-PEGDA scaffolds were 
explored, and their ability to promote cartilage growth from ASCs and serve as substrates for in 
vitro and in vivo implantations were studied.  The main conclusions of the thesis are: 
 Hyaluronic acid was functionalized with UV reactive glycidyl methacrylate at 8.2%, 
19.8% and 29.8% degrees of methacrylation, as confirmed by NMR spectroscopy. 
 Viscoelastic inks for direct-write assembly were formulated from 8.2% and 19.8% DM 
HAGM, PEGDA, glycerol, photoinitiator, and PBS. 3D hydrogel scaffolds were 
patterned with filament diameters ranging from 10µm to 250µm, and various pitch sizes, 
and overall dimensions.  They were UV cured during printing to ensure long-term 
structural stability. 
 The compressive moduli of printed HAGM-PEGDA scaffolds were related to their 
composition and 3D geometry.  Specific parameters were identified that produced 
scaffolds with mechanical properties akin to native tissues of interest, i.e., cartilage. 
 The injectable nature of HAGM-PEGDA scaffolds was demonstrated by flowing them 
through tapered microchannels, whose characteristic diameter was reduced by 16-fold to 
one-third of scaffold diameter, without evidence of structural damage. 
 Degradation of HAGM scaffolds in hyaluronidase was shown to be affected by PEDGA 
concentration, allowing for possible tailoring of degradation times in vivo by altering 
methacrylate cross-linker density. 
59 
 
 Cartilage growth on seeded HAGM scaffolds was shown by staining of 
glycosaminoglycans, and cartilage was better able to infiltrate 3D scaffold with 
incorporated cell-adhesive RGD peptide. 
 ASCs were seeded in 3D 2% bulk HAGM as a method for even cell distribution in 
printed 3D HAGM-PEGDA scaffolds.  Cells seeded in dilute HAGM demonstrated 
proliferation, mobility, and chondrogenic differentiation. 
 HAGM-PEGDA 3D scaffolds were implanted in porcine mandibles and proved to be 
biocompatible and able to support growth of new bone. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
 
REFERENCES 
1. Bajaj P, Marchwiany D, Duarte C, Bashir R (2012) Patterned Three-Dimensional 
Encapsulation of Embryonic Stem Cells using Dielectrophoresis and Stereolithography. 
Advanced Healthcare Materials: n/a-n/a. 
2. Gauvin R, Chen Y-C, Lee JW, Soman P, Zorlutuna P, et al. (2012) Microfabrication of 
complex porous tissue engineering scaffolds using 3D projection stereolithography. 
Biomaterials 33: 3824-3834. 
3. Melchels FPW, Bertoldi K, Gabbrielli R, Velders AH, Feijen J, et al. (2010) Mathematically 
defined tissue engineering scaffold architectures prepared by stereolithography. 
Biomaterials 31: 6909-6916. 
4. Zhang Y, Choi S-W, Xia Y (2012) Modifying the Pores of an Inverse Opal Scaffold With 
Chitosan Microstructures for Truly Three-Dimensional Cell Culture. Macromolecular 
Rapid Communications 33: 296-301. 
5. Barry RA, III, Shepherd RF, Hanson JN, Nuzzo RG, Wiltzius P, et al. (2009) Direct-Write 
Assembly of 3D Hydrogel Scaffolds for Guided Cell Growth. Advanced Materials 21: 
2407-+. 
6. Shepherd JNH, Parker ST, Shepherd RF, Gillette MU, Lewis JA, et al. (2011) 3D 
Microperiodic Hydrogel Scaffolds for Robust Neuronal Cultures. Advanced Functional 
Materials 21: 47-54. 
7. Miller JS, Stevens KR, Yang MT, Baker BM, Nguyen D-HT, et al. (2012) Rapid casting of 
patterned vascular networks for perfusable engineered three-dimensional tissues. Nature 
Materials 11: 768-774. 
8. Norotte C, Marga FS, Niklason LE, Forgacs G (2009) Scaffold-free vascular tissue 
engineering using bioprinting. Biomaterials 30: 5910-5917. 
9. Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, et al. (2007) Hyaluronic acid 
hydrogen for controlled self-renewal and differentiation of human embryonic stem cells. 
Proceedings of the National Academy of Sciences of the United States of America 104: 
11298-11303. 
10. Bencherif SA, Srinivasan A, Horkay F, Hollinger JO, Matyjaszewski K, et al. (2008) 
Influence of the degree of methacrylation on hyaluronic acid hydrogels properties. 
Biomaterials 29: 1739-1749. 
11. Yamanlar S, Sant S, Boudou T, Picart C, Khademhosseini A (2011) Surface functionalization 
of hyaluronic acid hydrogels by polyelectrolyte multilayer films. Biomaterials 32: 5590-
5599. 
12. Young JL, Engler AJ (2011) Hydrogels with time-dependent material properties enhance 
cardiomyocyte differentiation in vitro. Biomaterials 32: 1002-1009. 
13. Kolhar P, Kotamraju VR, Hikita ST, Clegg DO, Ruoslahti E (2010) Synthetic surfaces for 
human embryonic stem cell culture. Journal of Biotechnology 146: 143-146. 
14. Ouasti S, Donno R, Cellesi F, Sherratt MJ, Terenghi G, et al. (2011) Network connectivity, 
mechanical properties and cell adhesion for hyaluronic acid/PEG hydrogels. Biomaterials 
32: 6456-6470. 
15. Hwang NS, Varghese S, Zhang Z, Elisseeff J (2006) Chondrogenic differentiation of human 
embryonic stem cell-derived cells in arginine-glycine-aspartate modified hydrogels. 
Tissue Engineering 12: 2695-2706. 
61 
 
16. Shu XZ, Ghosh K, Liu YC, Palumbo FS, Luo Y, et al. (2004) Attachment and spreading of 
fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. Journal of 
Biomedical Materials Research Part A 68A: 365-375. 
17. Beasley KL, Weiss MA, Weiss RA (2009) Hyaluronic Acid Fillers: A Comprehensive 
Review. Facial Plastic Surgery 25: 86-94. 
18. Tan H, Chu CR, Payne KA, Marra KG (2009) Injectable in situ forming biodegradable 
chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials 
30: 2499-2506. 
19. Thibeault SL, Duflo S (2008) Inflammatory cytokine responses to synthetic extracellular 
matrix injection to the vocal fold lamina propria. Annals of Otology Rhinology and 
Laryngology 117: 221-226. 
20. Yoon SJ, Fang YH, Lim CH, Kim BS, Son HS, et al. (2009) Regeneration of Ischemic Heart 
Using Hyaluronic Acid-Based Injectable Hydrogel. Journal of Biomedical Materials 
Research Part B-Applied Biomaterials 91B: 163-171. 
21. Bencherif SA, Sands RW, Bhatta D, Arany P, Verbeke CS, et al. (2012) Injectable preformed 
scaffolds with shape-memory properties. Proceedings of the National Academy of 
Sciences of the United States of America 109: 19590-19595. 
22. Skardal A, Zhang J, McCoard L, Oottamasathien S, Prestwich GD (2010) Dynamically 
Crosslinked Gold Nanoparticle - Hyaluronan Hydrogels. Advanced Materials 22: 4736-+. 
23. Skardal A, Zhang J, Prestwich GD (2010) Bioprinting vessel-like constructs using 
hyaluronan hydrogels crosslinked with tetrahedral polyethylene glycol tetracrylates. 
Biomaterials 31: 6173-6181. 
24. Liu L, Liu Y, Li J, Du G, Chen J (2011) Microbial production of hyaluronic acid: current 
state, challenges, and perspectives. Microbial Cell Factories 10. 
25. Toole BP (2004) Hyaluronan: From extracellular glue to pericellular cue. Nature Reviews 
Cancer 4: 528-539. 
26. Seidlits SK, Khaing ZZ, Petersen RR, Nickels JD, Vanscoy JE, et al. (2010) The effects of 
hyaluronic acid hydrogels with tunable mechanical properties on neural progenitor cell 
differentiation. Biomaterials 31: 3930-3940. 
27. Smeds KA, Grinstaff MW (2001) Photocrosslinkable polysaccharides for in situ hydrogel 
formation. Journal of Biomedical Materials Research 54: 115-121. 
28. Nettles DL, Vail TP, Morgan MT, Grinstaff MW, Setton LA (2004) Photocrosslinkable 
hyaluronan as a scaffold for articular cartilage repair. Annals of Biomedical Engineering 
32: 391-397. 
29. Burdick JA, Chung C, Jia XQ, Randolph MA, Langer R (2005) Controlled degradation and 
mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules 
6: 386-391. 
30. Baier Leach J, Bivens KA, Patrick Jr CW, Schmidt CE (2003) Photocrosslinked hyaluronic 
acid hydrogels: Natural, biodegradable tissue engineering scaffolds. Biotechnology and 
Bioengineering 82: 578-589. 
31. Shu XZ, Liu YC, Luo Y, Roberts MC, Prestwich GD (2002) Disulfide cross-linked 
hyaluronan hydrogels. Biomacromolecules 3: 1304-1311. 
32. Mergy J, Fournier A, Hachet E, Auzely-Velty R (2012) Modification of polysaccharides via 
thiol-ene chemistry: A versatile route to functional biomaterials. Journal of Polymer 
Science Part a-Polymer Chemistry 50: 4019-4028. 
62 
 
33. Jha AK, Hule RA, Jiao T, Teller SS, Clifton RJ, et al. (2009) Structural Analysis and 
Mechanical Characterization of Hyaluronic Acid-Based Doubly Cross-Linked Networks. 
Macromolecules 42: 537-546. 
34. Piluso S, Hiebl B, Gorb SN, Kovalev A, Lendlein A, et al. (2011) Hyaluronic acid-based 
hydrogels crosslinked by copper-catalyzed azide-alkyne cycloaddition with tailorable 
mechanical properties. International Journal of Artificial Organs 34: 192-197. 
35. Darr A, Calabro A (2009) Synthesis and characterization of tyramine-based hyaluronan 
hydrogels. Journal of Materials Science-Materials in Medicine 20: 33-44. 
36. Yoo HS, Lee EA, Yoon JJ, Park TG (2005) Hyaluronic acid modified biodegradable 
scaffolds for cartilage tissue engineering. Biomaterials 26: 1925-1933. 
37. Zhang J, Skardal A, Prestwich GD (2008) Engineered extracellular matrices with cleavable 
crosslinkers for cell expansion and easy cell recovery. Biomaterials 29: 4521-4531. 
38. Park YD, Tirelli N, Hubbell JA (2003) Photopolymerized hyaluronic acid-based hydrogels 
and interpenetrating networks. Biomaterials 24: 893-900. 
39. Lee H, Park TG (2009) Photo-crosslinkable, biomimetic, and thermo-sensitive pluronic 
grafted hyaluronic acid copolymers for injectable delivery of chondrocytes. Journal of 
Biomedical Materials Research Part A 88A: 797-806. 
40. Chung C, Burdick JA (2008) Engineering cartilage tissue. Advanced Drug Delivery Reviews 
60: 243-262. 
41. Zarek JM, Edwards J (1963) The stress-structure relationship in articular cartilage. Med 
Electr and Biol Engng 1: 497-507. 
42. Fung YC (1993) Biomechanics: Mechanical properties of living tissues, second edition. 
xviii+568p-xviii+568p p. 
43. Williams AR, Hare JM (2011) Mesenchymal Stem Cells Biology, Pathophysiology, 
Translational Findings, and Therapeutic Implications for Cardiac Disease. Circulation 
Research 109: 923-940. 
44. Friedenstein AJ, Gorskaja UF, Kulagina NN (1976) FIBROBLAST PRECURSORS IN 
NORMAL AND IRRADIATED MOUSE HEMATOPOIETIC ORGANS. Experimental 
Hematology 4: 267-274. 
45. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage 
potential of adult human mesenchymal stem cells. Science 284: 143-147. 
46. Kern S, Eichler H, Stoeve J, Klueter H, Bieback K (2006) Comparative analysis of 
mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. 
Stem Cells 24: 1294-1301. 
47. Gimble JM, Katz AJ, Bunnell BA (2007) Adipose-derived stem cells for regenerative 
medicine. Circulation Research 100: 1249-1260. 
48. Ingber DE (2004) The mechanochemical basis of cell and tissue regulation. Mechanics & 
chemistry of biosystems : MCB 1: 53-68. 
49. Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage 
specification. Cell 126: 677-689. 
50. Kilian KA, Bugarija B, Lahn BT, Mrksich M (2010) Geometric cues for directing the 
differentiation of mesenchymal stem cells. Proceedings of the National Academy of 
Sciences of the United States of America 107: 4872-4877. 
51. Fu J, Wang Y-K, Yang MT, Desai RA, Yu X, et al. (2010) Mechanical regulation of cell 
function with geometrically modulated elastomeric substrates. Nature Methods 7: 733-
U795. 
63 
 
52. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, et al. (1997) Reversion of the 
malignant phenotype of human breast cells in three-dimensional culture and in vivo by 
integrin blocking antibodies. Journal of Cell Biology 137: 231-245. 
53. Garreta E, Genove E, Borros S, Semino CE (2006) Osteogenic Differentiation of Mouse 
Embryonic Stem Cells and Mouse Embryonic Fibroblasts in a Three-Dimensional Self-
Assembling Peptide Scaffold. Tissue Engineering Part A 12: 2215-2227. 
54. Caliari SR, Harley BAC (2011) The effect of anisotropic collagen-GAG scaffolds and 
growth factor supplementation on tendon cell recruitment, alignment, and metabolic 
activity. Biomaterials 32: 5330-5340. 
55. Dai W, Kawazoe N, Lin X, Dong J, Chen G (2010) The influence of structural design of 
PLGA/collagen hybrid scaffolds in cartilage tissue engineering. Biomaterials 31: 2141-
2152. 
56. Kang HG, Kim SY, Lee YM (2006) Novel porous gelatin scaffolds by overrun/particle 
leaching process for tissue engineering applications. Journal of Biomedical Materials 
Research Part B-Applied Biomaterials 79B: 388-397. 
57. Vaquette C, Frochot C, Rahouadj R, Wang X (2008) An innovative method to obtain porous 
PLLA scaffolds with highly spherical and interconnected pores. Journal of Biomedical 
Materials Research Part B-Applied Biomaterials 86B: 9-17. 
58. Harris LD, Kim BS, Mooney DJ (1998) Open pore biodegradable matrices formed with gas 
foaming. Journal of Biomedical Materials Research 42: 396-402. 
59. Salerno A, Oliviero M, Di Maio E, Iannace S, Netti PA (2009) Design of porous polymeric 
scaffolds by gas foaming of heterogeneous blends. Journal of Materials Science-
Materials in Medicine 20: 2043-2051. 
60. Venugopal J, Prabhakaran MP, Zhang Y, Low S, Choon AT, et al. (2010) Biomimetic 
hydroxyapatite-containing composite nanofibrous substrates for bone tissue engineering. 
Philosophical Transactions of the Royal Society a-Mathematical Physical and 
Engineering Sciences 368: 2065-2081. 
61. Ji Y, Ghosh K, Shu X, Li B, Sokolov J, et al. (2006) Electrospun three-dimensional 
hyaluronic acid nanofibrous scaffolds. Biomaterials 27: 3782-3792. 
62. Harley BAC, Gibson LJ (2008) In vivo and in vitro applications of collagen-GAG scaffolds. 
Chemical Engineering Journal 137: 102-121. 
63. Choi S-W, Xie J, Xia Y (2009) Chitosan-Based Inverse Opals: Three-Dimensional Scaffolds 
with Uniform Pore Structures for Cell Culture. Advanced Materials 21: 2997-3001. 
64. Lee J, Shanbhag S, Kotov NA (2006) Inverted colloidal crystals as three-dimensional 
microenvironments for cellular co-cultures. Journal of Materials Chemistry 16: 3558. 
65. Lee K-W, Wang S, Fox BC, Ritman EL, Yaszemski MJ, et al. (2007) Poly(propylene 
fumarate) bone tissue engineering scaffold fabrication using stereolithography: Effects of 
resin formulations and laser parameters. Biomacromolecules 8: 1077-1084. 
66. Melchels FPW, Barradas AMC, van Blitterswijk CA, de Boer J, Feijen J, et al. (2010) Effects 
of the architecture of tissue engineering scaffolds on cell seeding and culturing. Acta 
Biomaterialia 6: 4208-4217. 
67. Fu Q, Saiz E, Tomsia AP (2011) Direct ink writing of highly porous and strong glass 
scaffolds for load-bearing bone defects repair and regeneration. Acta Biomaterialia 7: 
3547-3554. 
68. Iwami K, Noda T, Ishida K, Morishima K, Nakamura M, et al. (2010) Bio rapid prototyping 
by extruding/aspirating/refilling thermoreversible hydrogel. Biofabrication 2. 
64 
 
69. Ovsianikov A, Deiwick A, Van Vlierberghe S, Pflaum M, Wilhelmi M, et al. (2011) Laser 
Fabrication of 3D Gelatin Scaffolds for the Generation of Bioartificial Tissues. Materials 
4: 288-299. 
70. Phillippi JA, Miller E, Weiss L, Huard J, Waggoner A, et al. (2008) Microenvironments 
engineered by inkjet bioprinting spatially direct adult stem cells toward muscle- and 
bone-like subpopulations. Stem Cells 26: 127-134. 
71. Xu T, Zhao W, Zhu J-M, Albanna MZ, Yoo JJ, et al. (2013) Complex heterogeneous tissue 
constructs containing multiple cell types prepared by inkjet printing technology. 
Biomaterials 34: 130-139. 
72. Khalil S, Sun W (2009) Bioprinting Endothelial Cells With Alginate for 3D Tissue 
Constructs. Journal of Biomechanical Engineering-Transactions of the Asme 131. 
73. Kim SS, Kang MS, Lee KY, Lee MJ, Wang L, et al. (2012) Therapeutic Effects of 
Mesenchymal Stem Cells and Hyaluronic Acid Injection on Osteochondral Defects in 
Rabbits' Knees. Knee Surgery & Related Research 24: 164. 
74. Murphy JM, Fink DJ, Hunziker EB, Barry FP (2003) Stem cell therapy in a caprine model of 
osteoarthritis. Arthritis and Rheumatism 48: 3464-3474. 
75. Yoon I-S, Chung CW, Sung J-H, Cho H-J, Kim JS, et al. (2011) Proliferation and 
chondrogenic differentiation of human adipose-derived mesenchymal stem cells in 
porous hyaluronic acid scaffold. Journal of Bioscience and Bioengineering 112: 402-408. 
76. Tan HP, Chu CR, Payne KA, Marra KG (2009) Injectable in situ forming biodegradable 
chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials 
30: 2499-2506. 
77. Erickson IE, Huang AH, Chung C, Li RT, Burdick JA, et al. (2009) Differential Maturation 
and Structure-Function Relationships in Mesenchymal Stem Cell- and Chondrocyte-
Seeded Hydrogels. Tissue Engineering Part A 15: 1041-1052. 
78. O'Leary MA, Grillone GA (2006) Injection laryngoplasty. Otolaryngologic Clinics of North 
America 39: 43-+. 
79. Pan L, Ren Y, Cui F, Xu Q (2009) Viability and Differentiation of Neural Precursors on 
Hyaluronic Acid Hydrogel Scaffold. Journal of Neuroscience Research 87: 3207-3220. 
80. Lewis JA (2006) Direct ink writing of 3D functional materials. Advanced Functional 
Materials 16: 2193-2204. 
81. Hansen CJ, White SR, Sottos NR, Lewis JA (2011) Accelerated Self-Healing Via Ternary 
Interpenetrating Microvascular Networks. Advanced Functional Materials 21: 4320-
4326. 
82. Hansen CJ, Wu W, Toohey KS, Sottos NR, White SR, et al. (2009) Self-Healing Materials 
with Interpenetrating Microvascular Networks. Advanced Materials 21: 4143-+. 
83. Therriault D, Shepherd RF, White SR, Lewis JA (2005) Fugitive inks for direct-write 
assembly of three-dimensional microvascular networks. Advanced Materials 17: 395-+. 
84. Conrad JC, Lewis JA (2010) Structural Evolution of Colloidal Gels During Constricted 
Microchannel Flow. Langmuir 26: 6102-6107. 
85. Lewis JA, Smay JE, Stuecker J, Cesarano J, III (2006) Direct ink writing of three-
dimensional ceramic structures. Journal of the American Ceramic Society 89: 3599-3609. 
86. Michna S, Wu W, Lewis JA (2005) Concentrated hydroxyapatite inks for direct-write 
assembly of 3-D periodic scaffolds. Biomaterials 26: 5632-5639. 
65 
 
87. Simon JL, Michna S, Lewis JA, Rekow ED, Thompson VP, et al. (2007) In vivo bone 
response to 3D periodic hydroxyapatite scaffolds assembled by direct ink writing. Journal 
of Biomedical Materials Research Part A 83A: 747-758. 
88. Sun LP, Sara T; Syoji, Daisuke; Wang, Xuilu; Lewis, Jennifer; Kaplan, David (2012) 
Direct=write Assembly of 3D Silk/Hydroxyapatite Scaffolds for Bone Co-Cultures. 
Advanced Healthcare Materials 1: 729-735. 
89. Lewis JA, Matsuyama H, Kirby G, Morissette S, Young JF (2000) Polyelectrolyte effects on 
the rheological properties of concentrated cement suspensions. Journal of the American 
Ceramic Society 83: 1905-1913. 
90. Adams JJ, Duoss EB, Malkowski TF, Motala MJ, Ahn BY, et al. (2011) Conformal Printing 
of Electrically Small Antennas on Three-Dimensional Surfaces. Advanced Materials 23: 
1335-1340. 
91. Ahn BY, Lorang DJ, Lewis JA (2011) Transparent conductive grids via direct writing of 
silver nanoparticle inks. Nanoscale 3: 2700-2702. 
92. Russo A, Ahn BY, Adams JJ, Duoss EB, Bernhard JT, et al. (2011) Pen-on-Paper Flexible 
Electronics. Advanced Materials 23: 3426-+. 
93. Ahn BY, Duoss EB, Motala MJ, Guo X, Park S-I, et al. (2009) Omnidirectional Printing of 
Flexible, Stretchable, and Spanning Silver Microelectrodes. Science 323: 1590-1593. 
94. Ghosh S, Parker ST, Wang X, Kaplan DL, Lewis JA (2008) Direct-write assembly of 
microperiodic silk fibroin scaffolds for tissue engineering applications. Advanced 
Functional Materials 18: 1883-1889. 
95. Wu W, DeConinck A, Lewis JA (2011) Omnidirectional Printing of 3D Microvascular 
Networks. Advanced Materials 23: H178-H183. 
96. Wu W, Hansen CJ, Aragon AM, Geubelle PH, White SR, et al. (2010) Direct-write assembly 
of biomimetic microvascular networks for efficient fluid transport. Soft Matter 6: 739-
742. 
97. Bitter T, Muir HM (1962) A MODIFIED URONIC ACID CARBAZOLE REACTION. 
Analytical Biochemistry 4: 330-&. 
98. Kim D, Monaco E, Maki A, de Lima AS, Kong HJ, et al. (2010) Morphologic and 
transcriptomic comparison of adipose- and bone-marrow-derived porcine stem cells 
cultured in alginate hydrogels. Cell Tissue Res 341: 359-370. 
99. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human 
adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228. 
100. Liu Z, Song J, Wang Z, Tian J, Kong Q, et al. (2008) Green fluorescent protein (GFP) 
transgenic pig produced by somatic cell nuclear transfer. Chinese Science Bulletin 53: 
1035-1039. 
101. Zhang L, Su P, Xu C, Yang J, Yu W, et al. (2010) Chondrogenic differentiation of human 
mesenchymal stem cells: a comparison between micromass and pellet culture systems. 
Biotechnol Lett 32: 1339-1346. 
102. Bian L, Hou C, Tous E, Rai R, Mauck RL, et al. (2013) The influence of hyaluronic acid 
hydrogel crosslinking density and macromolecular diffusivity on human MSC 
chondrogenesis and hypertrophy. Biomaterials 34: 413-421. 
103. Farndale RW, Buttle DJ, Barrett AJ (1986) Improved quantitation and discrimination of 
sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 
883: 173-177. 
66 
 
104. Maki AJ, Clark SG, Woodard JR, Goldwasser M, Wheeler MB (2010) 108 A CRITICAL-
SIZE CRANIOFACIAL BONE DEFECT MODEL IN THE YORKSHIRE PIG. 
Reproduction, Fertility and Development 23: 159-159. 
105. Wilson SM, Goldwasser MS, Clark SG, Monaco E, Bionaz M, et al. (2012) Adipose-
derived mesenchymal stem cells enhance healing of mandibular defects in the ramus of 
swine. J Oral Maxillofac Surg 70: e193-203. 
106. Shepard N, Mitchell N (1976) Simultaneous localization of proteoglycan by light and 
electron microscopy using toluidine blue O. A study of epiphyseal cartilage. Journal of 
Histochemistry & Cytochemistry 24: 621-629. 
107. Yoon HH, Bhang SH, Shin J-Y, Shin J, Kim B-S (2012) Enhanced Cartilage Formation via 
Three-Dimensional Cell Engineering of Human Adipose-Derived Stem Cells. Tissue 
Engineering Part A 18: 1949-1956. 
108. Delise AM, Tuan RS (2002) Analysis of N-cadherin function in limb mesenchymal 
chondrogenesis in vitro. Developmental Dynamics 225: 195-204. 
109. Denker AE, Nicoll SB, Tuan RS (1995) Formation of cartilage-like spheroids by micromass 
cultures of murine C3H10T1/2 cells upon treatment with transforming growth factor-β1. 
Differentiation 59: 25-34. 
110. Heng BC, Cao T, Lee EH (2004) Directing stem cell differentiation into the chondrogenic 
lineage in vitro. Stem Cells 22: 1152-1167. 
111. Yoshimura K, Sato K, Aoi N, Kurita M, Inoue K, et al. (2008) Cell-assisted lipotransfer for 
facial lipoatrophy: Efficacy of clinical use of adipose-derived stem cells. Dermatologic 
Surgery 34: 1178-1185. 
 
 
